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ABSTRACT 
 
As the world’s population grows older, cognitive disorders are becoming more common.  
 
It is estimated that to date more than 20 million people worldwide have dementia, and the total  
prevalence of dementia is predicted to quadruple by 2040 due to demographic changes as well as  
increasing longevity. Currently, there is no cure for cognitive decline or dementia; therefore,  
finding lifestyle interventions which decrease the risk of cognitive decline or preserve cognitive  
function are of the utmost importance. This thesis comprises four manuscripts that explore the  
inter-relationships between physical activity, various lifestyle factors and cognitive function at  
different points across the lifespan. 
Studies one and two used data from the 2012 annual component of the Canadian  
Community Health Survey and studies three and four used data from the Midlife in the  
US (MIDUS) survey. The first study assessed the associations between physical activity,  
sedentary time, obesity (body mass index), and cognitive function in younger and older Canadian  
adults. The second study explored the relationships between physical activity, daily fruit and  
vegetable consumption, obesity (body mass index), and cognitive function in younger and older  
Canadian adults. The third study evaluated the inter-relationships between physical activity,  
number of medications used (type II diabetes, high blood pressure, high cholesterol), obesity  
(waist-to-hip ratio) and cognitive function in adults between the ages of 25 to 84 years.  
The fourth study considered the relationships between physical activity, engagement in  
cognitively stimulating activities, obesity (waist-to-hip ratio) and cognitive function in adults  
between the ages of 25 to 84 years. 
Collectively, the findings of these studies contribute to a better understanding of the  
relationships that exist between lifestyle variables and cognitive function across the adult  
lifespan. 
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CHAPTER 1: GENERAL INTRODUCTION 
As people age, they change in numerous ways, both biologically and psychologically.  
There is sufficient evidence that alterations in brain structure and function are closely tied to  
alterations in cognitive function (Raz, 2000). Age-related changes in cognitive function vary  
considerably across individuals and across cognitive domains, with some cognitive functions  
appearing more susceptible to the effects of ageing than others (Raz, 2000). The basic cognitive  
functions that seem most affected by age are attention and memory, although higher-level  
functions such as language processing and decision making, may also be affected (Verhaeghen &  
Cerella, 2002). Moreover, complex cognitive tasks may also depend on a set of executive  
functions (controls goal oriented behaviors such as problem solving, multitasking, and plan  
making)
 
(Verhaeghen & Cerella, 2002).  Evidence points to executive functioning impairments  
as contributors to declines in cognitive functioning that may result in a Mild Cognitive  
Impairment (MCI) or a dementia spectrum disorder
 
(Bishop et al., 2010; Hedden & Gabrieli,  
2004). Bearing in mind the increase in the proportion of older adults, it is important to identify a  
means for maintaining cognitive integrity by protecting against, or even counteracting, some of  
the adverse effects of the ageing process
 
(Bishop et al., 2010; Hedden & Gabrieli, 2004). 
Dementia means “loss of mind” and is a neurological condition characterized by both 
cognitive as well as functional impairments; individuals eventually lose their independence and 
become unable to perform the typical activities of daily living (Gelder et al., 2006). Dementia is 
a syndrome that is affecting an ever-increasing number of people due to the ageing of 
populations globally. According to Alzheimer’s Disease International (ADI), 24.3 million people 
were living with dementia in 14 World Health Organization (WHO) regions in 2001, and this is 
estimated to reach 81.1 million by 2040, with the number doubling every 20 years
 
(Prince et al., 
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2013). In 2010, the global prevalence of dementia for age 60y+ was 4.7% with a regional 
prevalence of 2.6% in Africa, 4.0% in Asia, 6.2% in Europe and 6.9% in North America
 
(Sosa-
Ortiz et al., 2012). The Global Burden of Disease has estimated that dementia accounts for 
11.2% of disability years in people over 60 years, a value higher than stroke (9.5%), 
cardiovascular diseases (5.0%), musculoskeletal disorders (8.9%) and all forms of cancer (2.4%)
 
(Ferri et al., 2005). These facts and figures emphasize the importance of developing preventative 
strategies in order to reduce the burden of this disease on society as well as ease the suffering of 
those affected both directly and indirectly (e.g. family members). 
Cognitive Function 
 
Cognitive function is brain function. An adult human brain weighs approximately 3  
 
pounds
 
(Clarke & Sokoloff, 1999; Kramer & Erickson, 2007), is smaller in women than  
 
men, and encompasses about 2% of total body mass. As people age, the weight and volume  
 
of their brains decreases, with a loss of between 5%-10% in their later years
 
(Clarke &  
 
Sokoloff, 1999; Kramer & Erickson, 2007). The brain works even when the individual is at rest,  
 
although it works harder when the individual thinks, speaks, reads, plans or acts. All that work  
 
depends on the body’s ability to deliver oxygen and glucose to the cerebrovascular system and  
 
on that system’s ability to route blood to the active neurons. The brain’s functioning depends  
 
heavily on cardiovascular, respiratory, and metabolic health
 
(Kramer & Erickson, 2007; Cotman  
 
et al., 2007; Hillman et al., 2008; Kumari et al., 2000; Spiro et al., 2008).  
 
Human brains age at different rates due to factors such as genetic make-up and  
 
environmental variables
 
(Clarke & Sokoloff, 1999; Kramer & Erickson, 2007). To a large  
 
degree, lifestyle behaviors define the non-genetic elements that affect the brain. If the ageing  
 
process in the brain is accelerated for any reason, neurons are damaged and dementia emerges
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(Kramer & Erickson, 2007). 
 
Research has shown that dementia spectrum disorders are characterized by varying 
patterns of impairment. Alzheimer’s Disease is characterized by impairment of episodic memory 
(verbal and non-verbal) initially, followed by dysfunctions in judgment and abstract reasoning, 
visual construction, verbal fluency and naming (Gelder et al., 2006). Patients with vascular 
dementia tend to be significantly more impaired than patients with AD on tests of executive 
function such as verbal fluency, and their level of memory impairment usually tends to be less 
severe (Gelder et al., 2006). In fronto-temporal dementia, letter fluency and executive function 
are usually worse than in AD, while memory performance is usually better. Dementia with lewy 
bodies is characterized by a dysfunction in attention, visuospatial tasks, letter fluency, mental 
tracking and abstract reasoning (Gelder et al., 2006). 
Successful cognitive ageing is defined as:  
‘‘Not just the absence of cognitive impairment, but the development and preservation of the 
multi-dimensional cognitive structure that allows the older adult to maintain social 
connectedness, and ongoing sense of purpose, and the abilities to function independently, to 
permit functional recovery from illness and injury, and to cope with residual cognitive deficits 
(Hendrie & Albert, 2006).’’ 
 
The main elements of this definition are that successful cognitive ageing combines  
multiple cognitive domains, extending beyond traditional neuropsychological abilities, such as  
memory and executive functions, to more esoteric constructs such as wisdom and resilience. In  
addition, this definition considers the link between cognitive health with functional independence  
and engagement with life (Hendrie & Albert, 2006). 
Risk Factors 
 
Genetics. 
 
The apolipoprotein E (APOE) e4 allele is the main genetic risk factor for AD. The APOE  
 
e4 allele increases the risk for AD in a dose-response manner, where those with homozygous e4  
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allele have a higher risk than individuals with heterozygous e4 allele, who in turn have a higher  
 
risk than individuals with no e4 copies (Qiu et al., 2004). It has been estimated that 15%-20% of  
 
dementia and AD are attributable to the APOE e4 allele (Frikke-Schmidt et al., 2001). Genetic  
 
causes of AD include autosomal-dominant mutations in three genes (Presenilin 1 (PSEN1),  
 
Presenilin 2 (PSEN2) and the amyloid precursor protein (APP), which are implicated in early- 
 
onset AD and account for approximately 1% of all cases (Solomon et al., 2014; Wu et al., 2012) 
 
Age. 
 
Age is the leading risk factor for cognitive decline and dementia, with risk for both  
Alzheimer’s disease (AD) and vascular dementia (VaD) doubling every 5 years over the age of  
65
 
(Wimo & Prince, 2010; Lobo et al., 2000). Age-dependent associations with dementia/AD  
 
have been suggested for several ageing-related medical conditions. For example, elevated blood  
 
pressure, body mass index (BMI: kg/m
2
), and total cholesterol levels at a young age and in  
 
middle age (<65 years) are associated with an increased risk of dementia and AD, and having  
 
lower values in late life (>75 years) is also associated with subsequent development of  
 
dementia/AD
 
(Qiu et al., 2005; Qiu et al., 2010; Kivipelto et al., 2005). Diabetes mellitus has  
 
also been associated with increased risk of dementia and AD throughout adulthood, but the risk  
 
is stronger when diabetes occurs in mid-life compared to late-life
 
(Arvanitakis et al., 2004). 
 
Obesity.  
Among older adults, a low or declining BMI is generally indicative of an unhealthy loss 
of muscle, bone density, and an increase in body fat resulting from inactivity, poor nutrition, and 
an accumulation of chronic conditions (Dziura et al., 2004; Kahng et al., 2004). However, the 
relationship between BMI and cognitive decline and dementia is largely dependent on the time of 
onset as well as duration of BMI and body weight change. Compared to normal BMI (18.5-24.9), 
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underweight was not significantly associated with AD (Anstey et al., 2011; Xu et al., 2011; 
Fitzpatrick et al., 2009; Beydoun et al., 2008; Whitmer et al., 2007). Additionally, obesity (BMI 
≥30) in later life (≥60 years of age) appears to be inversely associated with dementia compared 
to normal weight, reducing the risk of dementia by 21%
 
(Luchsinger et al., 2012). Among seniors 
who have been overweight or obese for a long period of time, remaining so may be a relatively 
good sign for cognitive function
 
(Kuo et al., 2006). For middle-aged adults, however, higher 
BMI is associated with lower cognitive function and faster subsequent decline
 
(Cournot et al., 
2006; Sabia et al., 2009). Cournot and colleagues (2006) found that a higher BMI was associated 
with lower cognitive scores after adjustment for age, sex, educational level, blood pressure, 
diabetes, and other psychosocial factors. A higher BMI was also associated with a higher 
cognitive decline at follow-up, after adjustment for confounders (Cournot et al., 2006). Sabia and 
colleagues (2009)
 
found that both underweight and obesity were associated with lower cognition 
in late midlife and with early adulthood, early midlife, and late midlife measures of BMI. Being 
obese on two or three occasions was associated with lower Mini-Mental State Examination 
scores, scores of memory and executive function in analyses adjusted for age, sex, and level of 
education compared with the normal-weight group. Participants who were underweight on two 
or more occasions from early adulthood to late midlife had lower executive function. Further, a 
large increase in BMI from early to late midlife was associated with lower executive function
 
(Sabia et al., 2009). Compared to normal weight individuals, obese individuals in midlife (40-59 
years of age) had a nearly twofold, greater risk for all types of any dementia, and a modestly 
higher risk for AD (Xu et al., 2011; Fitzpatrick et al., 2009; Beydoun et al., 2008; Whitmer et al., 
2005; Whitmer et al., 2008; Rosengren et al., 2005; Wimo & Prince, 2010; Whitmer et al., 2007).  
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Obesity and a sedentary lifestyle are believed to accelerate ageing in all of the body's 
organs, including the brain. In general, weight is gained over the life span, but this weight 
increase is considered to level off around the age of 65–70 years, and weight loss is associated 
with an increased risk of death in late life (Dziura et al., 2004; Kahng et al., 2004). However, 
older adults today are heavier and have been overweight for a longer period of time than in 
previous generations
 
(Hedley et al., 2004). Given that excess body weight is a global health 
problem, with more than 60% of the US and European adult populations being overweight or 
obese, even a small adverse effect on cognitive abilities might have a detrimental effect on public 
health
 
(Hedley et al., 2004).  
Excess adiposity with many measures of physiological dysfunction may be associated 
with poorer cognitive functioning (Abraham et al., 2007; Kumari et al., 2000). Moreover, BMI is 
related to other factors such as high blood pressure, high ratios of low-density to high-density 
lipoprotein, type II diabetes, insulin resistance and high blood glucose, heart disease, stroke, and 
signs of the inflammatory processes that contribute to the formation of atherosclerotic plaques 
and embolisms that may weaken cognitive functioning (Hillman et al., 2008; Abraham et al., 
2007; Haffner, 2006; Ogden et al., 2007). Poor cognitive function is related to type II diabetes 
and the metabolic syndrome (a cluster of metabolic risk factors), particularly in the presence of 
inflammation
 
(Morley, 2004; Arvanitakis et al., 2004). Any three of the following traits in the same 
individual meet the criteria for the metabolic syndrome: abdominal obesity (a waist 
circumference of 102 cm or more in men and 88 cm or more in women), serum triglycerides 
(150 mg/dl or above), HDL cholesterol (40mg/dl or lower in men and 50mg/dl or lower in 
women), blood pressure (of 130/85 or more), and fasting blood glucose (of 100 mg/dl or above)
 
(Morley, 2004).  Excess adiposity is associated with decreased levels of physical activity 
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engagement, which also contributes to cognitive decline, partly due to low aerobic capacity 
(Kramer & Erickson, 2007; Angevaren et al., 2008). Additionally, vascular risk factors such as 
type II diabetes and high blood pressure are recognized factors that influence cognition and are 
implicated in the evolution toward dementia (Xu et al., 2004; Shah et al., 2006). 
Type II Diabetes.  
Type II diabetes has increasingly been identified as a risk factor for cognitive impairment 
and dementia (Biessels et al., 2006; Luchsinger, 2008; Euser et al., 2010). Individuals with 
diabetes, even without a diagnosis of dementia, report poorer cognitive function when compared 
to those without diabetes in global tests of cognition, attention, executive function, processing 
speed, memory, and language, independent of other factors (Arvanitakis et al., 2004; Cukierman 
et al., 2005; Euser et al., 2010; Manschot et al., 2006; Verdelho et al., 2007).Type II diabetes 
promotes neuronal degeneration and increases risk of brain atrophy, the development of 
cognitive issues as well as dementia (Folch et al., 2013; Hayden et al., 2006; MacKnight et al., 
2002). Furthermore, it is a risk factor for AD, even more so when it is combined with smoking, 
high blood pressure or heart disease (Luchsinger et al., 2005; Arvanitakis et al., 2004; Abraham 
et al., 2007).
 
 The inter-relationship between blood glucose and insulin levels may also play a 
role in the development of dementia, as insulin appears to affect amyloid deposition, memory 
and cognitive processes (Luchsinger et al., 2005; Arvanitakis et al., 2004; Abraham et al., 2007). 
Hypertension. 
Hypertension in midlife has been consistently associated with later development of 
cognitive decline and dementia (Hénon et al., 2006; Qiu et al., 2009). High blood pressure alone 
damages the brain and speeds up the ageing process, possibly because it damages the small blood 
vessels, particularly in the white matter, producing innumerable silent "mini-strokes" and 
ischemic changes
 
(Goldstein et al., 2005). The large blood vessels that supply the brain (i.e. carotid 
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arteries) and the large and small blood vessels within the brain are also affected by hypertension. 
Such damage can disrupt the blood-brain barrier, thus allowing the entry of toxic substances into the 
brain. Other structural changes to the blood vessels that are common in hypertension decrease the 
blood supply to the brain. Healthy older adults who experience small increases in blood pressure 
over a five-year period displayed greater brain atrophy and white matter vascular lesions
 
(Goldstein et al., 2005). The higher the systolic blood pressure in a patient, the more brain 
damage was seen. High blood pressure in midlife is a major risk factor for dementia, but plays a 
prominent role at any point. Even minor elevations may negatively impact the brain (Goldstein et 
al., 2005).  
High Cholesterol.  
High cholesterol in midlife has also been associated with an increased risk of developing 
cognitive decline and dementia (Kivipelto et al., 2001), via atherosclerosis and CVD, as well as 
greater amyloid deposition in brain (Van Vliet et al., 2009; Solomon et al., 2007). Though, it is 
known that cardiovascular risk factors may contribute to cognitive decline, it remains unclear 
whether the medications used to treat these conditions may also be contributing to cognitive 
decline. 
Sedentary Time. 
Sedentary behavior is distinct from physical activity in that it is “any waking behaviour 
characterised by an energy expenditure ≤1.5 METs whilst in a sitting or reclining posture”. This 
definition includes activities such as sitting, lying down, watching television, reading, screen-
based entertainment and driving a vehicle (Ainsworth et al., 2000; Ainsworth et al., 2011). A 
growing body of epidemiological evidence has linked sedentary behaviour to health risks 
including an increased risk of type II diabetes (Proper et al., 2011; Van Uffelen et al., 2010), 
metabolic syndrome (Edwardson et al., 2012), cancer (Lynch, 2010), and all-cause and CVD 
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mortality (Proper et al., 2011; Van Uffelen et al., 2010). These associations are usually shown to 
be at least partially independent of levels of physical activity suggesting that sedentary 
behaviours have the potential to influence risk of disease, independent of physical activity levels 
typically recommended for good health. To date, the exact effects of sedentary time on cognitive 
functioning are unknown. 
Protective Factors 
Several protective factors for cognitive decline and dementia/AD have also been  
identified: these include higher socioeconomic status in early life and attaining a high level of  
education as well as a number of factors in adult life such as high work complexity, having a rich  
social network, mentally stimulating activity, non-smoking, and engagement in regular physical  
activity
 
(Qiu et al., 2009; Karp et al., 2009; Rovio et al., 2005). Living with a partner during mid-
life has also been associated with reduced risk of cognitive impairment and dementia later in life, 
suggesting that being in a relationship entails cognitive and social challenges that can increase 
the cognitive reserve, the ability of the human brain to cope with damage by using different brain 
processes to retain the ability to function well. Cognitive reserve is developed through 
intellectual stimulation and translates into a higher volume of connections between neurons and 
stronger rates of cerebral blood flow
 
(Hakansson et al., 2009). Even at older ages, active 
engagement in mental, physical, and social activities may postpone the onset of dementia by 
increasing the cognitive reserve
 
(Paillard-Borg et al., 2009). 
Physical Activity & Cognitive Function.  
Physical activity refers to body movement that is produced by the contraction of skeletal 
muscles and that increases energy expenditure. Exercise refers to planned, structured, and 
repetitive movement to improve or maintain one or more components of physical fitness
 
(Chodzko-Zajko et al., 2009).
 
Physical activity is an independent contributing factor of disability 
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and mortality, with estimates of 5-10% of deaths worldwide being due to physical inactivity
 
(World Health Organization, 2002). The benefits of physical activity are numerous and well 
established. These include a reduction in the risk of cardiovascular disease, hypertension, stroke, 
type II diabetes, obesity, osteoporosis, some forms of cancer as well as improvements in aspects 
of mental health
 
(Haskell et al., 2007). In addition, for older adults there is a growing body of 
evidence that physical activity reduces the risk of falls, reduces functional limitations and 
prevents or delays cognitive decline
 
(Nelson et al., 2007). 
 
Physical activity is important at every stage of life, but perhaps more so as people age 
(Kumari & Heese, 2010; Uchida et al., 2006; Joyner & Green, 2009; Biessels et al., 2006). 
Because of the positive effects listed above, risk of strokes, coronary artery disease, and all-cause 
mortality are decreased by engaging in physical activity (Abbott et al., 2004; Weuve et al., 2004; 
Biessels et al., 2006; Middleton et al., 2008). Endorphin levels are also elevated by aerobic 
exercise, reducing depression and anxiety (Abbott et al., 2004; Weuve et al., 2004; Van Gelder et 
al., 2004; Laurin et al., 2001; Cotman & Berchtold, 2002). Only recently, however, have 
investigators realized that physical activity also offers protection against cognitive decline and 
dementia, with an inverse correlation between the amount of exercise a person engages in and 
the possibility of experiencing cognitive decline. Studies have reported that people who regularly 
exercise have faster reaction times than those who do not, are able to discriminate between 
multiple stimuli better, can outperform those who are not physically active on tasks involving 
reasoning, working memory, and fluid intelligence tests (Abbott et al., 2004; Sun et al., 2010; 
Kramer et al., 1999). Current physical activity guidelines recommend engaging in moderate-
intensity aerobic activities for at least 30 or up to 60 (for greater benefit) minutes/day in bouts of 
at least 10 minutes each to total 150-300 minutes/week; or at least 20-30 minutes/day or more of 
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vigorous-intensity activities to total 75-150 minutes/week (American College of Sports 
Medicine, 2010). As well as resistance training (progressive weight training program or weight 
bearing calisthenics) (8-10 exercises involving the major muscle groups of 8-12 repetitions each) 
should be performed at least twice per week between a moderate and vigorous intensity
 
(American College of Sports Medicine, 2010). 
 In addition, frontal lobe functions, mainly executive ability, which deteriorate 
disproportionately with age, have been shown to improve in individuals on a walking regimen
 
(Abbott et al., 2004; Sun et al., 2010; Kramer et al., 1999). The Canadian Study of Health and 
Ageing, a large-scale population-based study, found reduced risk for AD with exercise and 
reported physical activity as a means to reduce risk for cognitive decline and dementia (Laurin et 
al., 2001; American College of Sports Medicine, 2010). Laurin and colleagues (2001) found that 
compared with no exercise, physical activity was associated with lower risks of cognitive 
impairment, AD and dementia. High levels of physical activity were associated with reduced 
risks of cognitive impairment, AD, and dementia of any type
 
(Laurin et al., 2001).  Larson and 
colleagues (2006) followed 1,740 older adults over a mean follow-up period of 6.2 years and 
found that the incidence rate of dementia was 13.0 per 1,000 person years for participants who 
exercised 3 or more times per week compared with 19.7 per 1,000 person years for those who 
exercised fewer than 3 times per week. Findings indicate that participants who exercised 3 or 
more times per week had a higher probability of being dementia-free than those who exercised 
fewer than 3 times per week (Larson et al., 2006). This can be interpreted to mean that there is an 
inverse relationship between levels of activity and risk of cognitive decline. 
The Nurse's Health Study involving 18,766 women from 70 to 81 years of age showed 
that higher levels of activity were associated with better cognitive performance
 
(Weuve et al., 
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2004). Compared with women in the lowest physical activity quintile, a 20% lower risk of 
cognitive impairment was found for women in the highest quintile of activity. Among women 
performing the equivalent of walking at an easy pace for at least 1.5 hours/week, mean global 
scores were 0.06 to 0.07 units higher compared with walking less than 40 min/week (P≤0.003). 
Less cognitive decline was also observed among women who were more active, especially those 
in the 2 highest quintiles of energy expenditure
 
(Weuve et al., 2004). The Honolulu-Asia Aging 
study reported similar findings. This study which involved 2,257 men, age 71 to 93 years, who 
were physically capable and cognitively intact on a screening test found an increased incidence 
of dementia in those who walked the shortest distance daily
 
(Abbott et al., 2004). After adjusting 
for age, men who walked the least (<0.25 mile/day) experienced a 1.8-fold excess risk of 
dementia compared with those who walked more than 2 miles per day. As well, compared with 
men who walked the most (>2 mile/day), an excess risk of dementia was observed in those who 
walked 0.25-1 miles per day
 
(Abbott et al., 2004). A recent longitudinal examination of 
approximately 13,000 individuals at least 70 years of age in the Nurses’ Health Study revealed 
that mid-life physical activity rates were significantly associated with higher survival rates
 
(Sun 
et al., 2010). After adjustment for covariates, higher physical activity levels at midlife, as 
measured by metabolic-equivalent tasks, were associated with greater odds of successful 
survival. Increasing energy expenditure from walking was associated with a similar elevation in 
odds of successful cognitive ageing
 
(Sun et al., 2010). Physical activity engagement prevents 
cognitive decline; this holds true for males and females, irrespective of study design.  
There are several ways in which physical activity helps protect and improve brain 
function. First, aerobic exercise reduces vascular risk factors including diabetes, hypertension, 
hyperlipidemia and coronary artery disease. The amount and intensity of physical activity is also 
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linked with the decrease that occurs in these risk factors. This makes it less likely that a person 
who is physically active will experience a stroke or significant cerebrovascular disease
 
(Lee et 
al., 2003). There have been a number of studies suggesting that physical activity also exerts an 
effect on the brain, producing anatomic changes while augmenting memory
 
(Van Pragg, 2009). It 
has been suggested that physical activity could preserve neuronal structure and promote the 
expansion of neural fibers, synapses and capillaries (Abbott et al., 2004; Van Pragg, 2009); for 
example, in laboratory animals who were placed on an exercise program, those who were the 
most active had larger hippocampi (Van Pragg, 2009; Romano, 2004). Physical activity seems to 
enhance neurogenesis in the brains of young rats as well as older ones, and may moderate age-
related decline in neural structures, as well as increase neuron proliferation (Van Pragg, 2009; 
Churchill et al., 2002). Neurogenesis has been demonstrated specifically in the hippocampus and 
cerebral cortex, and an increase in synaptic connections between neurons has also been shown. 
In addition, cardiovascular fitness appeared to be correlated with the thickness of the brain's 
cortical tissue (the gray matter where the neurons are located) (Van Pragg, 2009; Romano, 2004; 
Radak et al., 2007; Stranahan et al., 2009). 
Finally, physical activity promotes angiogenesis, the growth of new capillaries from 
preexisting arteries, which has been found to occur in the brains of laboratory animals exposed to 
exercise
 
(Van Pragg, 2009; Churchill et al., 2002). This may begin days after an exercise regimen 
is initiated, supporting heightened neuronal activity via increased blood flow and delivery of 
oxygen, glucose and other nutrients to brain tissue. It should also be noted that physical activity 
might improve cognitive function because of its overall impact on vitality and biological ageing. 
People who are physically active are generally healthier than their peers who are not. 
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These findings indicate that engagement in physical activity contributes to improvements 
to cognitive functioning domains. However, all of the research to date is focused on an older 
adult population, and it is unclear if the benefits of physical activity and cognitive function 
extend to younger adults, and whether there are critical time points across the lifespan.   
Fruit and Vegetable Consumption & Cognitive Function.  
 Diets that are high in fruits and vegetables are widely recommended due to their health 
promoting properties. Fruits and vegetables are rich sources of antioxidant nutrients and 
bioactive compounds (e.g., vitamin E, vitamin C, carotenoids, flavonoids). As well, 
epidemiological and laboratory studies, show that these micronutrients have been related to 
cognitive benefits (Lindeman et al., 2000; Morris et al., 2001; Cotman et al., 2002; Vermeer et 
al., 2002; Floyd & Hensley, 2002; Proteggente et al., 2002). As well, laboratory data suggest that 
the combinations of nutrients available in fruits and vegetables might have greater health benefits 
than single-vitamin supplements (Joseph et al., 1999). Animal studies have shown that 
antioxidants prevent neuronal damage and improve cognitive performance (Cotman et al., 2002; 
Joseph et al., 1999). For example, Joseph and colleagues (1999) found that rats who were given 
spinach, strawberries, or vitamin E, in doses with equivalent antioxidant potency, exhibited 
superior neuronal function compared to control animals.  
Consumption of fruit and vegetables has been strongly associated with reduced risk of 
CVD, cancer, diabetes, and age-related functional decline (Hung et al., 2004; Temple, 2000; 
Willett, 1994). In a population-based cohort study in The Netherlands, higher consumption of 
fruits and vegetables was found to be protective against the incidence of coronary heart disease 
(CHD) (Oude et al., 2010). Coronary heart disease incidence was 34% lower for individuals with 
a high intake of total fruit and vegetables compared to those with a low total fruit and vegetable 
consumption (Oude et al., 2010). A systematic review and meta-analysis of fruit and vegetable 
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intake and the incidence of type II diabetes showed that a greater intake of vegetables was 
associated with a 14% reduction in risk of type II diabetes (P = 0.01). As well, higher intakes of 
fruit were associated with a lower risk of type II diabetes (Carter et al., 2010; Wedick et al., 
2012). In another systematic review, the relationship between fruit and vegetable intake and 
adiposity was explored (Ledoux et al., 2011). It was determined that an inverse relationship 
exists between fruit and vegetable intake and adiposity (Ledoux et al., 2011). The study of the 
relationship between the consumption of vegetables and fruits on human health is greatly 
complicated by many factors, including varying dietary patterns and interactions with other 
dietary elements and to date the associations between the consumption of fruit and vegetables 
and cognitive function remain unclear. 
Cognitive Stimulation & Cognitive Function.  
Longitudinal studies assessing the associations between cognitively stimulating activities 
and the incidence of dementia have shown that engaging in complex mental activities is 
protective against the development of dementia (Verghese, 2003). A systematic review of 
observational studies evaluated population-based cohorts and showed that higher educational 
attainment, cognitively stimulating lifestyle activities, and greater occupational complexity 
offered protection against the development of dementia (Valenzuela & Sachdev, 2006). The 
ACTIVE trial, a key study in this field, randomized individuals into four groups: a 10-session 
group training for i) memory (verbal episodic memory), ii) reasoning (ability to solve problems 
that follow a serial pattern), iii) speed of processing (visual search and identification) or iv) a 
control group (n = 704). Results indicated significant improvements in 87% of participants 
trained in processing speed, 74% of participants trained in reasoning, and 26% of memory-
trained participants and demonstrated reliable cognitive improvement immediately after the 
intervention period. Cognitive improvements were maintained at the second year of follow-up 
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(Ball, 2002). A 5-year follow-up of the same population showed that cognitively trained subjects 
had improved cognitive abilities specific to the abilities trained that persisted after the 
intervention was stopped, compared to the control group (Willis, 2006).  
Although the mechanisms are not completely understood, engagement in cognitively 
stimulating activities may contribute to an increase in cognitive reserve. Cognitive reserve 
describes the notion that a greater number of neurons and higher intelligence can protect an 
individual from faster cognitive decline or a dementia spectrum disorder (Valenzuela, 2008). 
Cognitive reserve involves neuro-flexibility where the end goal is adaption. Individuals with a 
higher cognitive reserve have a larger repertoire of strategies to resolve complicated tasks. 
Therefore, when a particular neuronal network malfunctions, other networks can be used to solve 
the same problems (Stern, 2002).  
CONCEPTUAL FRAMEWORK 
 
A well-known theoretical model depicting the inter-relationships between physical  
 
activity, cognitive function, and lifestyle factors across the lifespan does not exist; hence, this  
 
dissertation proposes and implements such a model. This framework proposes a life-course  
 
approach and indicates that interactions and joint effects exist between physical activity and  
 
lifestyle variables, anthropometry, and age. In this project the lifestyle variables that are explored  
 
are sedentary time, fruit and vegetable consumption, the number of medications used, and  
 
engagement in cognitively stimulating activities. Anthropometry refers to overweight/obesity  
 
status, which will be measured as body mass index (BMI) or waist-to-hip-ratio (WHR).  Finally,  
 
life cycle refers to age. Further, this model also indicates that an interaction exists between  
 
physical activity and cognitive function. The lifestyle variables that were selected in this project  
 
were chosen because they are all modifiable and can all be performed and accomplished by the  
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individual. As well, the obesity variable was included in each of the projects because of the  
 
increasing prevalence in both the American and Canadian populations. Obesity is a disease but it  
 
also serves as a risk factor for other conditions. However, it was considered separately from  
 
physical activity and the lifestyle variables because its relationship with ageing is a unique one-  
 
its changing relationship with cognitive function (i.e. being overweight/obese at midlife is bad  
 
for cognitive function, whereas in late life it is protective). As people age, they tend to  
 
accumulate risk factors and develop unhealthy habits which tend to contribute to poor health.  
 
The concept of disease prevention implies the acquirement of behaviors and habits which would  
 
subsequently reduce the risk of disease. Although dementia is viewed as a disease of older  
 
adults, because symptoms manifest themselves in later years, cognitive declines may be  
 
occurring years or decades prior to when the overt symptoms become present.  
 
Figure 1-1: General theoretical model illustrating the potential relationships between lifestyle, 
anthropometry, physical activity and cognitive health, across the lifespan. 
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This thesis is presented in manuscript format and consists of four manuscripts. The 
manuscripts are followed by a general discussion of the main findings, public health 
implications, strengths and limitations of the research, as well as future directions. 
Specific Objectives 
Study 1: To determine the associations between physical activity, sedentary time, obesity, and 
cognitive functioning in younger and older Canadian adults. In this study, lifestyle will be 
captured using sedentary time; anthropometry will be captured using body mass index (BMI), 
and; physical activity will be captured using the physical activity index (PAI). 
Study 2: To determine the associations between physical activity, total daily fruit and vegetable 
consumption, obesity, and cognitive functioning in younger and older Canadian adults. In this 
study, lifestyle will be captured using total daily fruit and vegetable consumption; anthropometry 
will be captured using body mass index (BMI), and; physical activity will be captured using the 
physical activity index (PAI). 
Study 3: To determine the inter-relationships between increased medication use (for conditions  
 
such as high blood pressure, type II diabetes, and high cholesterol), physical activity, obesity, 
and cognitive function in younger, middle-aged and older American adults. In this study, 
lifestyle will be captured using medication use; anthropometry will be captured using waist-to-
hip ratio (WHR), and; physical activity will be captured using a series of question regarding the 
frequency of engagement in moderate-to-vigorous physical activity (MVPA). 
Study 4: To determine the inter-relationships between cognitive stimulation (reading, attending  
 
lectures/courses, playing card games, playing word games), physical activity, obesity, and  
 
cognitive function in younger, middle-aged and older American adults. In this study, lifestyle  
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will be captured using cognitive stimulation; anthropometry will be captured using waist-to-hip  
 
ratio (WHR), and; physical activity will be captured using a series of question regarding the  
 
frequency of engagement in moderate-to-vigorous physical activity (MVPA). 
 
Data Sources 
This project involved four secondary data analyses. The first two studies use data from 
the 2012 annual component of the Canadian Community Health Survey (CCHS). Briefly, the 
CCHS is a cross-sectional survey that collects information related to health status, health care 
utilization and health determinants for the Canadian population. It surveys a large sample of 
respondents and is designed to provide reliable estimates at the health region level.  
Using computer-assisted interviews, the CCHS recruits persons aged 12 and over living 
in private dwellings in the 10 provinces and three territories, representing 98% of the population. 
Informed consent was obtained from each respondent by Statistics Canada, in accordance with 
Canadian federal legislative requirements. The analyses included all respondents between the 
ages of 30 to 80+ years of age, with complete data for all study variables (n = 48,041), 
representing an estimated 21,523,898 Canadians. For a full list of the CCHS variables that were 
used, please refer to Appendix A. Separate ethics approval was not required for the current 
project as it involved secondary analysis of publicly available data. 
Studies three and four used data from MIDUS (Midlife in the U.S.) which is a national 
longitudinal study of the many factors (i.e. behavioral, social, psychological, biological, 
neurological) that come together to influence health and well-being as people age from early 
adulthood into midlife and old age. In 1995, MIDUS survey data were collected from a total of 
7,108 participants. All eligible participants were non-institutionalized English speaking adults in 
the contiguous United States, aged 25-74. All respondents were asked to participate in a phone 
interview of approximately 30 minutes in length and complete 2 self-administered 
20 
 
questionnaires. With funding from the National Institute on Aging, a longitudinal follow-up of 
MIDUS I began in 2004. Of the 7,108 in MIDUS I, 4,963 were successfully contacted to 
participate in MIDUS II. The overall response rate for the self-administered questionnaires was 
81%. For a full list of the MIDUS variables that were used, please refer to Appendix B. Separate 
ethics approval was not required for the current project as it involved secondary analysis of 
publicly available data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
REFERENCES 
 
Abbott, R.D., White, L.R., Ross, G.W., Masaki, K.H., Curb, J.D., Petrovitch, H. (2004). Walking 
and dementia in physically capable elderly men. Journal of the American Medical Association, 
292(12), 1447-1453. 
 
Abraham, N. G., Brunner, E. J., Eriksson, J. W., Robertson, R. P. (2007). Metabolic syndrome - 
Psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Annals of the New 
York Academy of Sciences, 1113, 256-275. 
 
Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., O'Brien, 
W.L., Bassett, D.R., Schmitz, K.H., Emplaincourt, P.O., Jacobs, D.R., Leon, A.S. (2000). 
Compendium of Physical Activities: An update of activity codes and MET intensities. Medicine 
& Science in Sports & Exercise, 32(9 Suppl), S498-S504. 
Ainsworth, B.E., Haskell, W.L., Herrmann, S.D., Meckes, N., Bassett, D.R., Tudor-Locke, C., 
Greer, J.L., Vezina, J., Whitt-Glover, M.C., Leon, A.S. (2011). 2011 Compendium of Physical 
Activities. Medicine & Science in Sports & Exercise, 43 (8), 1575-1581. 
American College of Sports Medicine. (2010). ACSM’s guidelines for exercise testing and 
prescription (8th ed.). New York: Lippincott Williams & Wilkins. 
Angevaren, M., Aufdemkampe, G., Verhaar, H. J., Aleman, A.,Vanhees, L. (2008). Physical 
activity and enhanced fitness to improve cognitive function in older people without known 
cognitive impairment. Cochrane Database of Systematic Reviews, 3, CD005381. 
 
Anstey, K.J., Cherbuin, N., Budge, M., Young, J. (2011). Body mass index in midlife and latelife 
as a risk factor for dementia: a meta-analysis of prospective studies. Obesity Reviews, 12, e426-
e437. 
 
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., Bennett, D. A. (2004). Diabetes 
mellitus and risk of Alzheimer’s disease and decline in cognitive function. Archives of 
Neurology, 61, 661-666. 
 
Ball, K. (2002). Effects of cognitive training interventions with older adults: a randomized 
controlled trial. JAMA, 288, 2271–2281. 
Beydoun, M.A., Lhotsky, A., Wang, Y. (2008). Association of adiposity status and changes in 
early to mid-adulthood with incidence of Alzheimer’s disease. American Journal of 
Epidemiology, 168, 1179-1189. 
 
Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P. (2006). Risk of dementia 
in diabetes mellitus? A systematic review. Lancet Neurology, 5, 64–74. 
22 
 
Bishop, N.A., Lu, T., Yankner, B.A. (2010). Neural mechanisms of ageing and cognitive 
decline. Nature, 464, 529-535. 
Carter, P., Gray, L.J., Troughton, J., Khunti, K., Davies, M.J. (2010). Fruit and vegetable intake 
and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ, 18(341), 
c4229. 
 
Chodzko-Zajko, W.J., Proctor, D.N., Fiatarone Singh, M.A. (2009). American College of Sports 
Medicine position stand. Exercise and physical activity for older adults. Medicine and Science in 
Sports and Exercise, 41(7), 1510-1530.  
Clarke, D. D., Sokoloff, L. (1999). Circulation and energy metabolism of the brain. Basic 
neurochemistry: Molecular, cellular and medical aspects, Sixth edition (Chapter 31). Lippincott, 
Williams, and Wilkins. 
Churchill,J.D., Galvez, R., Colcombe, S., Swain, R.A., Kramer, A.F., Greenough, W.T. (2002). 
Exercise, experience and the aging brain.  Neurobiology of Ageing, 23, 941-955. 
Cotman, C.W., Berchtold, N. (2002). Exercise: A behavioral intervention to enhance brain health 
and plasticity. Trends in Neurosciences, 25, 295-301. 
Cotman, C.W., Head, E., Muggenburg, B.A. (2002). Brain aging in the canine: a diet enriched in 
antioxidants reduces cognitive dysfunction. Neurobiology of Aging, 23, 809–818. 
Cotman, C.W., Berchtold, N.C., Christie, L. (2007). Exercise builds brain health: Key roles of 
growth factor cascades and inflammation. Trends in Neurosciences, 9, 464–472. 
 
Cournot, M., Marquié, J. C., Ansiau, D., Martinaud, C., Fonds, H., Ferrières, J., Ruidavets, J. B. 
(2006). Relation between body mass index and cognitive function in healthy middle-aged men 
and women. Neurology, 67, 1208–1214. 
 
Cukierman, T., Gerstein, H.C., Williamson, J.D. (2005). Cognitive decline and dementia in 
diabetessystematic overview of prospective observational studies. Diabetologia, 48, 2460–2469. 
 
Dziura, J., De Leon, C. M., Kasl, S., DiPietro, L. (2004). Can physical activity attenuate aging-
related weight loss in older people? The Yale Health Study, 1982–1994. American Journal of 
Epidemiology, 159, 759–767. 
 
Edwardson, C.L., Gorely, T., Davies, M.J., Gray, L.J., Khunti, K. (2012). Association of 
sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One, 7, e34916. 
Euser, S.M., Sattar, N., Witteman, J.C., Bollen, E.L., Sijbrands, E.J., Hofman, A., Perry, I.J., 
Breteler, M.M., Westendorp, R.G. (2010). PROSPER and Rotterdam Study. A prospective 
analysis of elevated fasting glucose levels and cognitive function in older people: results from 
PROSPER and the Rotterdam Study. Diabetes, 59, 1601–1607. 
 
23 
 
Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M. (2005). Global 
prevalence of dementia: a Delphi consensus study. Lancet, 366(9503), 2112–2117. 
 
Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L. (2009). Midlife and late-life obesity and the risk of 
dementia: cardiovascular health study. Archives of Neurology, 66, 336-342. 
 
Floyd, R.A., Hensley, K. (2002). Oxidative stress in brain aging. Implications for therapeutics of 
neurodegenerative diseases. Neurobiology of Aging, 23, 795– 803. 
Folch, J., Pedrós, I., Patraca, I., Martínez, N., Sureda, F., Camins, A. (2013). Metabolic basis of 
sporadic Alzheimer’s disease. Role of hormones related to energy metabolism. Current 
Pharmaceutical Design, 19(38), 6739–6748. 
 
Frikke-Schmidt, R., Nordestgaard, B.G., Thudium, D., Moes Grønholdt, M.L., Tybjaerg-Hansen, 
A. (2001). APOE genotype predicts AD and other dementia but not ischemic cerebrovascular 
disease. Neurology, 56, 194-200. 
 
Gelder, M., Mayou, R., Geddes, J. (2006). Psychiatry, 3rd ed. Oxford: Oxford University Press. 
Goldstein, I.B., Bartzokis, G., Guthrie, D., Shapiro, D. (2005). Ambulatory blood pressure and 
the brain. Neurology, 64, 1846-1852. 
Haffner, S. M. (2006). Risk constellations in patients with the metabolic syndrome: 
Epidemiology, diagnosis, and treatment patterns. American Journal of Medicine, 119, 35-95. 
 
Hakansson, K., Rovio, S., Helkala, E.L., Vilska, A.R., Winblad, B., Soininen, H., Nissinen, A., 
Mohammed, A.H., Kivipelto, M. (2009).  Association between mid-life marital status and 
cognitive function in later life: population based cohort study. BMJ, 339, b2462. DOI: 
10.1136/bmj.b2462. 
 
Haskell, W.L., Lee, I.M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Bauman, A. 
(2007). Physical activity and public health: Updated recommendation for adults from the 
American College of Sports Medicine and the American Heart Association. Circulation, 116, 
1081–1093. 
 
Hayden, K.M., Zandi, P.P., Lyketsos, C.G. (2006). Vascular risk factors for incident Alzheimer 
disease and vascular dementia: the Cache County study. Alzheimer Disease and Associated 
Disorders, 20, 93-100. 
Hedden, T., Gabrieli, J.D. (2004). Insights into the ageing mind: a view from cognitive 
neuroscience. Nature Reviews Neuroscience, 5, 87-96. 
Hedley, A.A., Ogden, C.L., Johnson, C.L. (2004). Prevalence of overweight and obesity among 
US children, adolescents, and adults, 1999–2002. Journal of the American Medical Association, 
291(23), 2847-2850. 
 
24 
 
Hendrie, H., Albert, M. (2006). The NIH cognitive and emotional health project: report of the 
critical evaluation study committee. Alzheimer’s & Dementia: The Journal of the Alzheimer’s 
Association, 2(1), 12–32. 
Hénon, H., Pasquier, F., Leys, D. (2006). Poststroke dementia. Cerebrovascular Diseases, 22, 
61–70. 
 
Hillman, C. H., Erickson, K. I., Kramer, A. F. (2008). Be smart, exercise your heart: Exercise 
effects on brain and cognition. Nature Reviews Neuroscience, 9, 58–65. 
 
Hung, H.C., Joshipura, K.J., Jiang, R., Hu, F.B., Hunter, D., Smith-Warner, S.A., 
Colditz, G.A., Rosner, B., Spiedelman, D., Willett, W.C. (2004). Fruit and vegetable intake and 
risk of major chronic disease. Journal of  the National Cancer Institute, 96, 1577–1584. 
 
Joseph, J.A., Shukitt-Hale, B., Denisova, N.A. (1999). Reversals of age-related declines in 
neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or 
strawberry dietary supplementation. The Journal of Neuroscience, 19, 8114–8121. 
Joyner, M.J., Green, D.J. (2009). Exercise protects the cardiovascular system: effects beyond traditional 
risk factors. Journal of Physiology, 578, 5551-5558. 
Karp, A., Andel, R., Parker, M.G., Wang, H.X., Winblad, B., Fratiglioni, L. (2009). Mentally 
stimulating activities at work during midlife and dementia risk after age 75: follow-up study 
from the Kungsholmen Project. American Journal of Geriatric Psychiatry, 17, 227-236. 
 
Kahng, S. K., Dunkle, R. E., Jackson, J. S. (2004). The relationship between the trajectory of 
body mass index and health trajectory among older adults. Research on Aging, 26, 31–61. 
Kivipelto, M., Helkala, E.L., Laakso, M.P., Hanninen, T., Hallikainen, M., Alhainen, K. (2001). 
Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based 
study. BMJ, 322(7300), 1447–1451.  
 
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kareholt, I., Winblad, B., Helkala, E.L., 
Tuomilehto, J., Soininen, H., Nissinen, A. (2005). Obesity and vascular risk factors at midlife 
and the risk of dementia and Alzheimer disease. Archives of Neurology, 62, 1556-1560. 
 
Kivipelto, M., Rovio, S., Ngandu, T., Kåreholt, I., Eskelinen, M., Winblad, B., Hachinski, V., 
Cedazo-Minguez, A., Soininen, H., Tuomilehto, J., Nissinen, A. (2008). Apolipoprotein E 
epsilon4 magnifies lifestyle risks for dementia: a population-based study. Journal of Cellular 
and Molecular Medicine, 12, 2762-2771. 
Kramer, A.F., Hahn, S., Cohen, N., Banich, M., McAuley, E., Harrison, C. (1999). Aging, fitness 
and neurocognitive function. Nature, 400, 418-419. 
Kramer, A. F., Erickson, K. I. (2007). Capitalizing on cortical plasticity: Influence of physical 
activity on cognition and brain function. Trends in Cognitive Sciences, 11, 342–348. 
25 
 
 
Kumari, M., Brunner, E., Fuhrer, R. (2000). Minireview: Mechanisms by which the metabolic 
syndrome and diabetes impair memory. Journal of Gerontology: Biological Sciences, 55(A), 
B228–B232. 
 
Kumari, U., Heese, K. (2010). Cardiovascular dementia: a different perspective. Open 
Biochemistry Journal, 4, 29-52. 
 
Kuo, H. K., Jones, R. N., Milberg, W. P., Tennstedt, S., Talbot, L., Morris, J. N., Lipsitz, L. A. 
(2006). Cognitive function in normal-weight, overweight, and obese older adults: An analysis of 
the Advanced Cognitive Training for Independent and Vital Elderly Cohort. Journal of the 
American Geriatric Society, 54, 97–103. 
 
Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P.K. (2006). Exercise 
is associated with reduced risk for incident dementia among persons 65 years of age and older. 
Annals of Internal Medicine, 144(2), 73-82. 
 
Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., Rockwood, K. (2001). Physical activity 
and risk of cognitive impairment and dementia in elderly persons. Archives of Neurology, 58, 
498-504. 
 
Ledoux, T.A., Hingle, M.D., Baranowski, T. (2011). Relationship of fruit and vegetable intake 
with adiposity: a systematic review. Obesity Reviews, 12, e143–e150. 
 
Lee, C.D., Folson, A.R., Blair, S.N. (2003). Physical activity and stroke risk: a meta-
analysis. Stroke, 34, 2475-2482. 
 
Lindeman, R.D., Romero, L.J., Koehler, K.M. (2000). Serum vitamin B12, C and folate 
concentrations in the New Mexico elder health surveys: correlations with cognitive and affective 
functions. The Journal of The American College of Nutrition, 19, 68-76.  
 
Lobo, A., Launer, L.J., Fratiglioni, L., Andersen, K., Di Carlo, A., Breteler, M.M., Copeland, 
J.R., Dartigues, J.F., Jagger, C., Martinez-Lage, J., Soininen, H., Hofman, A. (2000). Prevalence 
of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. 
Neurology, 54(11), S4-S9. 
Luchsinger, J., Reitz, C., Mayeux, R. (2005). Aggregation of vascular risk factors and risk of 
incident Alzheimer disease. Neurology, 65, 545-561. 
Luchsinger, J.A. (2008). Adiposity, hyperinsulinemia, diabetes and Alzheimer’s disease: an 
epidemiological perspective. European Journal of Pharmacology, 585, 119–129. 
 
Luchsinger, J.A., Cheng, D., Tang, M.X., Schupf, N., Mayeux, R. (2012). Central obesity in the 
elderly is related to late-onset Alzheimer disease. Alzheimer Disease and Associated Disorders, 
26(2), 101-105. 
 
26 
 
Lynch, B.M. (2010). Sedentary behavior and cancer: a systematic review of the literature and 
proposed biological mechanisms. Cancer Epidemiology, Biomarkers & Prevention, 19, 2691–
2709. 
 
MacKnight, C., Rockwood, K., Awalt, E., McDowell, I. (2002). Diabetes mellitus and the risk of 
dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of 
Health and Aging. Dementia and Geriatric Cognitive Disorders, 14, 77-83. 
 
Manschot, S.M., Brands, A.M., Van Der Grond, J., Kessels, R.P., Algra, A., Kappelle, L.J., 
Biessels, G.J. (2006). Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance 
imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes, 55, 1106–
1113. 
 
Middleton, L.E., Mitnitski, A., Fallah, N., Kirkland, S.A., Rockwood, K. (2008). Changes in 
Cognition and Mortality in Relation to Exercise in Late Life: A Population Based Study. PLoS 
ONE, 3(9), e3124. DOI:10.1371/journal.pone.0003124. 
Morley, J. E. (2004). The metabolic syndrome and aging. Journal of Gerontology: Medical Sciences, 
59(A), 139-142. 
Morris, M.S., Jacques, P.F., Rosenberg, I.H., Selhub, J. (2001). Hyperhomocysteinemia 
associated with poor recall in the third National Health and Nutrition Examination Survey. 
American Journal of Clinical Nutrition, 73, 927–933. 
 
Nelson, M.E., Rejeski, W.J., Blair, S.N. (2007). American College of Sports Medicine; 
American Heart Association. Physical activity and public health in older adults: recommendation 
from the American College of Sports Medicine and the American Heart Association. 
Circulation, 116(9), 1094-1105.  
 
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., Flegal, K. M. (2007). The epidemiology of 
obesity. Gastroenterology, 132, 2087-2102. 
 
Oude Griep, L.M., Gelejinse, J.M., Kronhout, D., Ocke, M.C., Verschuern, W.M. (2010). Raw 
and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a 
population-based cohort study in the Netherlands. PLoS ONE, 5, e13609. 
 
Paillard-Borg, S., Fratiglioni, L., Winblad, B.,Wang, H.X. (2009). Leisure activities in late life in 
relation to dementia risk: principal component analysis. Dementia and Geriatric Cognitive 
Disorders, 28,136-144. 
 
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P. (2013). The global 
prevalence of dementia: a systematic review and metaanalysis. Alzheimers & Dementia, 9(1), 63-
75.  
27 
 
Proper, K.I., Singh, A.S., Van Mechelen, W., Chinapaw, M.J.M. (2011). Sedentary behaviors 
and health outcomes among adults: A systematic review of prospective studies. American 
Journal of Preventative Medicine, 40, 174–182. 
Proteggente, A.R., Pannala, A.S., Paganga, G. (2002). The antioxidant activity of regularly 
consumed fruit and vegetables reflects their phenolic and vitamin C composition. Free Radical 
Research, 36, 217–233. 
Qiu, C., Kivipelto, M., Agüero-Torres, H., Winblad, B., Fratiglioni, L. (2004).Risk and 
protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: 
variation by age and sex. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 828-833. 
Qiu, C., Winblad, B., Fratiglioni, L. (2005). The age-dependent relation of blood pressure to 
cognitive function and dementia. Lancet Neurology, 4, 487-499. 
 
Qiu, C., Kivipelto, M., Von Strauss, E. (2009). Epidemiology of Alzheimer’s disease: 
occurrence, determinants, and strategies toward intervention. Dialogues in Clinical 
Neuroscience, 11, 111-128. 
 
Qiu, C., Xu, W., Fratiglioni, L. (2010). Vascular and psychosocial factors in Alzheimer’s 
disease: epidemiological evidence toward intervention. Journal of Alzheimers Disease, 20, 689-
697. 
 
Radak, Z., Kumagai, S., Taylor, A.W., Naito, H., Goto, S. (2007). Effects of exercise on brain 
function: role of free radicals. Applied Physiology, Nutrition, and Metabolism, 32, 942-946. 
Raz, N. (2000). Aging of the brain and its impact on cognitive performance: Integration of 
structural and functional findings. In F. Craik & T. Salthouse (Eds.). The Handbook of Aging and 
Cognition 2. Mahwah, New Jersey: Lawrence Erlbaum Associates. 
Romano, J.C. (2004). Modifiable risk factors for Alzheimer's disease. Neurology Reviews, 12(9), 
54-56. 
Rosengren, A., Skoog, I., Gustafson, D., Wilhelmsen, L. (2005). Body mass index, other 
cardiovascular risk factors, and hospitalization for dementia. Archives of Internal Medicine, 165, 
321-326. 
 
Rovio, S., Kareholt, I., Helkala, E.L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., 
Nissinen, A., Kivipelto, M. (2005). Leisure-time physical activity at midlife and the risk of 
dementia and Alzheimer’s disease. Lancet Neurology, 4, 705-711. 
 
Sabia, S., Kivimaki, M., Shipley, M. J., Marmot, M. G., Singh-Manouz, A. (2009). Body mass 
index over the adult life course and cognition in late midlife: The Whitehall II Cohort Study. 
American Journal of Clinical Nutrition, 89, 601–607. 
 
28 
 
Seripa, D., Panza, F., Franceschi, M., D‘Onofrio, G., Solfrizzi, V., Dallapiccola, B., Pilotto, A. 
(2009). Non-apolipoprotein, E, and apolipoprotein E genetics of sporadic Alzheimer’s disease. 
Ageing Research Reviews, 8, 214-236. 
Shah, R.C., Wilson, R.S., Bienias, J.L., Arvanitakis, Z., Evans, D.A., Bennett, D.A. (2006). 
Relation of blood pressure to risk of incident Alzheimer’s disease and change in global cognitive 
function in older persons. Neuroepidemiology, 26, 30–36. 
 
Solomon, A., Mangialasche, F., Richard, E., Andrieu, S., Bennett, D.A., Breteler, M., Fratiglioni, 
L., Hooshmand, B., Khachaturian, A.S., Schneider, L.S., Skoog, I., Kivipelto, M. (2014). 
Advances in the prevention of Alzheimer’s disease and dementia. Journal of Internal Medicine, 
275, 229-250. 
Solomon, A., Kareholt, I., Ngandu, T., Winblad, B., Nissinen, A., Tuomilehto, J. (2007). Serum 
cholesterol changes after midlife and late-life cognition: twenty-one year follow-up study. 
Neurology, 68(10), 751–756.  
 
Sosa-Ortiz, A.L., Acosta-Castillo, I., Prince, M.J. (2012). Epidemiology of dementias and 
Alzheimer’s disease. Archives of Medical Research, 43(8), 600–608.  
 
Spiro, A., Brady, C. B. (2008). Integrating health into cognitive aging research: Handbook of 
cognitive aging—Interdisciplinary perspectives, 260-283, Thousand Oaks, CA: Sage 
Publications. 
 
Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve 
concept. Journal of the International Neuropsychological Society, 8, 448–460. 
 
Stranahan AM, Zhou Y, Martin B, Maudsley S. (2009). Pharmacomimetics of exercise: novel 
approaches for hippocampally-targeted neuroprotective agents. Current Medicinal Chemistry, 
16, 4668-4678. 
 
Sun, Q., Townsend, M.K., Okerke, O.I., Franco, O.H., Hu, F.B., Grodstein, F. (2010). Physical 
activity at midlife in relation to successful survival in women at age 70 years or older. Archives 
of Internal Medicine, 170(2), 124-125. 
 
Temple, N.J. (2000). Antioxidants and disease: more questions than answers. Nutrition 
Research, 20, 449–459. 
 
Uchida, S., Suzuki, A., Kagitani, F., Hotta, H. (2006). Responses of acetylcholine release and 
regional blood flow in the hippocampus during walking in aged rats. Journal of Physiological 
Sciences, 56, 253-257. 
 
Valenzuela, M.J., Sachdev, P. (2006). Brain reserve and dementia: a systematic review. 
Psychological Medicine, 36, 441–454.  
29 
 
Valenzuela, M.J. (2008). Brain reserve and the prevention of dementia. Current Opinions in 
Psychiatry, 21, 296–302.  
Van Gelder, B.M., Tijhuis, M.A., Kalmijn, S., Giampaoli, S., Nissinen, A., Kromhout, D. (2004). 
Physical activity in relation to cognitive decline in elderly men. Neurology, 63, 2316–2321. 
Van Pragg, H. (2009). Exercise and the brain: something to chew on. Trends in Neurosciences, 
32, 283-290. 
 
Van Vliet, P., Van De Water, W., De Craen, A.J., Westendorp, R.G. (2009). The influence of age 
on the association between cholesterol and cognitive function. Experimental Gerontology , 44(1–
2), 112–122.  
 
Van Uffelen, J.G.Z., Wong, J., Chau, J.Y., Van Der Ploeg, H.P., Riphagen, I. (2010). 
Occupational Sitting and Health Risks A Systematic Review. American Journal of Preventative 
Medicine, 39, 379–388. 
Verdelho, A., Madureira, S., Ferro, J.M., Basile, A.M., Chabriat, H., Erkinjuntti, T., Fazekas, F., 
Hennerici, M., O’Brien, J., Pantoni, L., Salvadori, E., Scheltens, P., Visser, M.C., Wahlund, 
L.O., Waldemar, G., Wallin, A., Inzitari, D. (2007). Differential impact of cerebral white matter 
changes, diabetes, hypertension and stroke on cognitive performance among non-disabled 
elderly. The LADIS study. Journal of Neurology, Neurosurgery & Psychiatry, 78, 1325–1330. 
 
Verghese, J. (2003). Leisure activities and the risk of dementia in the elderly. New England 
Journal of Medicine, 348, 2508–2516.  
Verhaeghen, P., Cerella, J. (2002). Aging, executive control, and attention: a review of meta-
analyses. Neuroscience & Behavioral Reviews, 26, 849. 
 
Vermeer, S.E., van Dijk, E.J., Koudstaal, P.J. (2002). Homocysteine, silent brain infarcts, and 
white matter lesions: the Rotterdam Scan Study. Annals of Neurology, 51, 285–289. 
Voelker, R. (2008). Guideline: dementia drugs’ benefits uncertain. JAMA, 299, 1763. 
 
Wedick, N.M., Pan, A., Cassidy, A., Rimm, E.B., Sampson, L., Rosner, B., Willett, W., Hu, 
F.B., Sun, Q., Van Dam, R.M. (2012). Dietary flavonoid intakes and risk of type 2 diabetes in 
US men and women. American Journal of Clinical Nutrition, 95, 925–933. 
 
Weuve, J., Kang, J., Manson, J.E., Breteler, M.M.B., Ware, J.H., Grodstein, F. (2004). Physical 
activity, including walking, and cognitive function in older women. Journal of the American 
Medical Association, 292(12), 1454-1461. 
 
Whitmer, R.A., Gunderson, E.P., Barrett-Connor, E., Quesenberry, C.P., Yaffe, K. (2005). 
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. 
BMJ, 330(7504): 1360. 
 
30 
 
Whitmer, R.A., Gunderson, E.P., Quesenberry, C.P. Jr., Zhou, J., Yaffe, K. (2007). Body mass 
index in midlife and risk of Alzheimer disease and vascular dementia. Current Alzheimer 
Research, 4, 103-109. 
 
Whitmer, R.A., Gustafson, D.R., Barrett-Connor, E., Haan, M.N., Gunderson, E.P., Yaffe, K. 
(2008). Central obesity and increased risk of dementia more than three decades later. Neurology, 
7, 1057-1064. 
 
Willett, W.C. (1994). Diet and health: what should we eat? Science, 254, 532–537. 
 
Willis, S.L. (2006). Long-term effects of cognitive training on everyday functional outcomes in 
older adults. JAMA, 296, 2805–2814. 
Wimo, A., Prince, M. (2010). World Alzheimer Report 2010: The Global Economic Impact of 
Dementia. Alzheimer’s Disease International. 
 
World Health Organisation. (2002). World Health Report: Reducing Risks, Promoting Healthy 
Life. WHO, Geneva. 
 
Wu, L., Rosa-Neto, P., Hsiung, G.R., Sadovnick, A.D., Masellis, M., Black, S.E., Jia, J., 
Gauthier, S. (2012). Early-onset familial Alzheimer’s disease (EOFAD). The Canadian journal 
of neurological sciences. Le Journal Canadien des Sciences Neurologiques, 39, 436-445. 
Xu, W.L., Qiu, C.X., Wahlin, A., Winblad, B., Fratiglioni, L. (2004). Diabetes mellitus and risk 
of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology, 63, 1181–1186. 
 
Xu, W.L., Atti, A.R., Gatz, M., Pedersen, N.L., Johansson, B., Fratiglioni, L. (2011). Midlife 
overweight and obesity increase late-life dementia risk: a population-based twin study. 
Neurology, 76, 1568-1574. 
 
 
 
 
 
 
 
 
 
31 
 
 
 
 
 
 
 
 
 
CHAPTER 2: MANUSCRIPT 1 
 
Exploring the Inter-Relationships between Physical Activity, Body Mass Index, 
 
SedentaryTime and Cognitive Functioning In Younger and Older Canadian Adults: 
 
Analysis of Cross-Sectional Data 
 
This manuscript has been submitted to The Journal of Aging and Physical Activity, and is 
presented in a format that is consistent with journal requirements. 
 
 
 
 
 
 
  
32 
 
Abstract 
 
Background: Engagement in leisure-time physical activity (LTPA) is protective against  
 
cognitive decline whereas obesity and leisure-time sedentary time (LTST) are associated with  
 
impairments in cognitive function. Currently, little is known about how these relationships  
 
vary across the lifespan. 
 
Purpose: This study investigated the inter-relationships between LTPA, LTST, BMI and  
 
perceived cognitive functioning in younger and older Canadian adults. 
 
Methods: Data from the 2012 annual component of the Canadian Community Health Survey  
 
(N=45,522; ≥30y) were used to capture self-reported LTPA (kcal/kg/day, KKD), BMI (kg/m2),  
 
LTST, and perceived cognitive function. The inter-relationships were assessed using general  
 
linear models. 
 
Results: Lower LTPA, higher BMI and LTST, were related to poorer cognitive functioning  
 
(p<0.0001). This relationship becomes more pronounced with age. 
 
Conclusions: Across the lifespan Higher LTPA levels contribute to better perceived cognitive  
 
functioning both independently and by way of reducing BMI and LTST.  
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Introduction 
 
Dementia is a syndrome characterized by progressive deterioration in multiple cognitive  
 
domains, affecting an ever-increasing number of people due to the ageing of populations around  
 
the world. According to Alzheimer’s Disease International (ADI), 24.3 million people were  
 
living with dementia in 14 World Health Organization (WHO) regions in 2001, and this is  
estimated to reach 81.1 million by 2040, with the numbers doubling every 20 years (Prince et al.,  
2013). Age is the leading risk factor for cognitive decline and dementia, with risk for both  
Alzheimer’s disease (AD) and vascular dementia (VaD) doubling every 5 years over the age of  
65 (Wimo & Prince, 2010; Lobo et al., 2000). Among the factors that contribute to the onset of  
cognitive decline, excess adiposity, type II diabetes, elevated blood pressure, and mood disorder  
appear to be key (Qui et al., 2005; Kivipelto et al., 2005; Qui et al., 2010). Several protective  
elements have also been identified including attaining high levels of education, not smoking, and  
being married (Qui et al., 2009; Karp et al., 2009; Rovio et al., 2005). 
Perhaps most consistently, epidemiological research shows a relationship between higher  
levels of leisure time physical activity (LTPA) and reduced risk of cognitive decline. A meta- 
analysis of 16 prospective studies examining the relationship between LTPA and risk of  
neurodegenerative disease reported that engaging in the highest LTPA category had a 28% lower  
risk of dementia, compared to inactivity, even after adjusting for possible confounding factors  
including age, education, vascular risk factors, and other medical conditions (Hamer & Chida,  
2009). In a more recent meta-analysis of 15 prospective cohort studies, over thirty thousand  
healthy older adults were followed for periods of 1-12 years. Results showed that individuals  
who had higher levels of LTPA at baseline had a 38% lower risk of cognitive decline at follow- 
up compared to those who who were inactive (Sofi et al., 2010). As well, observational studies  
have linked low levels of walking, low LTPA and increased sedentary behaviors to declines in  
cognitive functioning (Scarmeas et al., 2001; Abbott et al., 2004). Sedentary behaviors are  
defined as activities that are performed in a seated or reclining posture, including television  
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viewing, computer-use, game-console use and reading (Sedentary Behaviour Research Network,  
2012). These activities are in the low energy expenditure range of 1.0 to 1.5 METs (Ainsworth et  
al., 2000). To make matters more complicated, adults can meet their public health guidelines on  
LTPA, but still be engaged in sedentary activities over prolonged periods of time throughout the  
day. 
The prevalence of overweight and obesity has greatly increased in both developed and 
developing countries and increasing evidence suggests adiposity increases the risk of cognitive 
decline and dementia (Anstey et al., 2011; Ng et al., 2014). Studies have shown a negative 
association between BMI and cognitive performance (Elias et al., 2012), in particular with 
measures of executive function (Gunstad et al., 2007). The potential underlying mechanisms 
linking higher BMI to dementia may include direct effects of adiposity (hyperinsulinemia, 
advanced glycosylation end products, adipokines and cytokines), as well as indirect effects 
(increases in the prevalence of other vascular risk factors and related cerebrovascular disease) 
(Luchsinger & Gustafson, 2009). 
Currently, it is unclear how factors such as LTPA, leisure time sedentary time (LTST), 
BMI, and cognitive functioning are inter-related, and whether these inter-relationships remain 
consistent with age. These relationships might be particularly relevant for older adults. Currently, 
people aged 65 years or older represent one of the fastest growing segments of the world’s 
population (WHO, 2011), and determining how to delay cognitive decline will be important for 
keeping people physically independent throughout later life. As people age, levels of LTPA tend 
to decrease, whereas engagement in LTST activities as well as obesity prevalence tend to 
increase (Flegal et al., 2012; Seguin et al., 2012; Hamer & Stamatakis, 2013). Therefore, the aim 
of this study was to investigate the inter-relationships between LTPA levels, LTST, obesity, and 
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perceived cognitive functioning scores in younger and older Canadian adults (30 years of age 
and older).  
Methods 
Sample 
 
This study used data from the 2012 annual component of the Canadian Community 
Health Survey (CCHS), a cross-sectional survey that collects information related to health status, 
health care utilization and health determinants for the Canadian population. Using computer-
assisted interviews, the CCHS recruits persons aged 12 and over living in private dwellings in 
the 10 provinces and three territories, representing 98% of the Canadian population. Informed 
consent was obtained from each respondent by Statistics Canada, in accordance with Canadian 
federal legislative requirements (Beland, 2002). To examine these relationships within a sample 
with adequate chronic disease risk factors, obesity, LTPA, and LTST to relate to cognitive 
functioning scores, the present analysis was limited to respondents 30 years of age and older. 
Respondents with answers of “not stated” or “refused” for other study variables were excluded, 
reducing the original sample size of 61 707 to a sample of n = 45 522 (representing a weighted 
sample of an estimated 21 million Canadians) with complete data for all study variables.  
Measures 
 
Leisure Time Physical Activity: 
 
LTPA was assessed using an adaptation of the Minnesota Leisure Time Physical Activity 
Questionnaire (Taylor et al., 1978). Respondents were asked about their LTPA participation, 
indicating participation frequency within the past 3 months as well as average session duration. 
Average daily energy expended during LTPA was calculated, weighting activities by the 
associated metabolic equivalent of task (MET) value. Average daily energy expenditure was 
calculated by multiplying the number of times the activity was performed by the average 
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duration of the activity by the energy cost. The energy expenditure of other activities was 
expressed in multiples of METs. For example, standing requires approximately 2 METs 
(Ainsworth et al., 2000; Ainsworth et al., 2011). Results were expressed in kilocalories per 
kilogram per day (KKD) and used to classify participants as active (≥3.0 KKD), moderately 
active (1.5–2.9 KKD), or inactive (<1.5 KKD). Here, the active category (3.0 KKD) reflects, on 
average, the equivalent of 60 minutes of moderate-intensity activity daily (Schmitz, Kruse & 
Tress, 2000). The Physical Activity Index demonstrates very good reliability (r=0.90) and 
criterion validity (r=0.36) when compared with physical activity measured by alternative 
questionnaire-based methods (r=0.77) (Craig, Russell & Cameron, 2002). 
Leisure Time Sedentary Time: 
 
LTST was assessed by self-report. Participants were asked how many hours per week (in 
the past 3 months) they typically spent doing the following 4 activities outside of work: watching 
TV, playing video games, using computers, or reading. This was a categorical variable that 
measured the total number of hours per week engaging in LTST activities ranging from less than 
5 hours to 45 or more hours per week. 
            Anthropometry:  
 
Height and weight were self-reported and BMI was calculated as weight (kg) per height  
(m
2
). Participants were classified based on Canadian and World Health Organization guidelines  
as underweight (≤18.49 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25–29.9 kg/m2),  
or obese (≥30 kg/m2) (Health Canada, 2003; WHO, 2000). 
Age: 
 
Participants were asked to select their age from one of 16 possible categories. For the 
purposes of this analysis, only categories 6 (30-34 years of age) through 16 (80+ years of age) 
were analyzed. 
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Perceived Cognitive Functioning 
Perceived cognitive functioning was measured using the Cognition Attribute of the  
Health Utilities Index (HUI). The HUI provides a standardized measure of health status and  
Health Related Quality of Life (HRQL) (Patrick & Erickson, 1993). It describes an individual’s  
functional health status using eight basic attributes: vision, hearing, speech, ambulation,  
dexterity, emotion, cognition, and pain. Each attribute has five or six levels, ranging from normal  
to severely limited (or the complete absence of) functioning. HUI has been used in a wide variety  
of populations and clinical studies including stroke (Pickard et al., 2004; Grootendorst et al.,  
2000), various cancers (Whitton et al., 1997), type II diabetes (Maddigan et al., 2004), Alzheimer  
disease (Neumann et al., 2000), and many others in a wide variety of pediatric and adult  
populations. Health status at a point in time is described by an 8-element vector, one level for  
each of the 8 attributes. Furthermore, correlations among attributes in HUI are very low (unlike  
other instruments), therefore each attribute contributes new information (Houle & Berthelot,  
2000). The HUI system has strong test re-test reliability, validity and internal consistency  
(Cronbach’s α=0.81), and it is a very good discriminator of disease-related quality of life at the  
population level (Horsman et al., 2003; Furlong et al., 2001). The cognition attribute of the HUI  
has 6 levels of ability/disability: level 1 (able to remember most things, think clearly and solve  
day-to-day problems), level 2 (able to remember most things, but have a little difficulty when  
trying to think and solve day-to-day problems), level 3 (somewhat forgetful, but able to think  
clearly and solve day-to-day problems), level 4 (somewhat forgetful, and have a little difficulty  
when trying to think and solve day-to-day problems), level 5 (very forgetful, and have great  
difficulty when trying to think or solve day-to-day problems), level 6 (unable to remember  
anything at all, and unable to think or solve day-to-day problems). A higher score indicates a  
poorer level of functioning. 
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Covariates: 
 
Given the well-researched relationship between the primary exposure and outcome  
variables in these analyses, sex, marital status (married/common-law,   
widowed/separated/divorced, single/never married), level of education (less than secondary  
school grad, secondary school grad, some post-secondary school, post-secondary grad), smoking  
status (yes/no), high blood pressure (yes/no), diabetes (yes/no), and mood disorder (yes/no) were  
included as covariates (Barnes et al., 2004; Marx, 2005; Ngandu et al., 2007). Respondents with  
answers of ‘‘not stated’’ or ‘‘refused’’ for all study variables were excluded from the analyses. 
Statistical Analysis 
 
Participants were categorized into young-to-middle aged (30-59 y) and older (60-80+ y) 
groups on the basis of descriptive analyses that found that group differences in perceived 
cognitive functioning began to emerge at age 60 and above. Categorical variables are presented 
as frequencies and percentages, and continuous variables as means and standard deviations (SD). 
General linear models were used to determine the associations between BMI, LTPA or 
LTST, and perceived cognitive functioning, after adjusting for sex, education, marital status, 
smoking status, high blood pressure, diabetes, and mood disorder with cognitive functioning 
scores. Regression diagnostics were assessed, revealing no influential outlier observations and a 
normal distribution of residuals. Because the interactions between LTPA, LTST, BMI, cognitive 
functioning and age were significant (all p=<0.001), analyses were further stratified by age.  
Statistical analyses were performed using SAS v 9.4 (SAS Institute Inc., NC, USA) with 
statistical significance set at α<0.05. To ensure representativeness of the results to the Canadian 
population, data were weighed using the master weight in SAS survey procedures. 
Results 
 
Demographic and health characteristics of the population are presented in Table 1.  
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Participants were on average overweight (younger: µ=27.09±5.36; Older: µ=27.01±4.85), with  
 
about 59% of the younger adult population and 62% of the older adult population overweight or  
 
obese. Nearly 47% of the younger adults and 53% of the older adults were inactive, whereas only  
 
27% of the younger adults and 23% of the older adults were active. Overall, 23% of younger  
 
adults and 39% of older adults reported spending 30 or more hours per week engaged in LTST.  
 
As presented in Table 2, individuals who were more active reported superior perceived 
cognitive functioning scores compared to those who were moderately active or inactive (Active: 
µ=1.58±0.078; Moderately Active: µ=1.70±0.085; Inactive: µ=1.86±0.067; p<0.001). As well, 
younger adults reported better perceived cognitive functioning scores compared to older adults 
(Younger: µ=1.68±0.060; Older: µ=1.87±0.060; p<0.001). In regards to BMI and LTST, though 
insignificant in the unadjusted model, they both become strongly significant in the final model. 
Normal weight and overweight individuals reported better perceived cognitive functioning than 
obese individuals (Normal weight: µ=1.75±0.090; Overweight: µ=1.70±0.060; Obese: 
µ=1.82±0.077).  Participants who reported low and moderate levels of LTST reported better 
perceived cognitive functioning than those reporting high LTST (Low LTST: µ=1.74±0.078; 
Moderate LTST: µ=1.68±0.072; High LTST: µ=1.83±0.078). Also, individuals who were 
married/common-law, post-secondary graduates, non-smokers, and were otherwise healthy (i.e. 
non-diabetic, normotensive, and no reported mood disorder) reported better perceived cognitive 
functioning than individuals who were single/divorced/widowed, had lower levels of education, 
smokers, diabetics, hypertensive, and those who reported having a mood disorder. 
As shown in Figure 1, younger adults who were normal weight active and moderately 
active, overweight active and moderately active, and obese active  reported better perceived 
cognitive functioning scores than normal weight inactive, overweight inactive, and obese 
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moderately active and inactive. In older adults, normal weight active, overweight moderately 
active, and obese active reported better perceived cognitive functioning scores than normal 
weight moderately active and inactive, overweight active and inactive, and obese moderately 
active and inactive (Figure 1).  
In regards to LTPA, in younger adults, lower levels of LTPA, higher BMI and LTST 
were associated with poorer perceived cognitive functioning scores. In older adults, this 
association was more pronounced (Figure 2). 
Discussion 
 
Age-related cognitive decline is an escalating worldwide public health concern. The  
 
prevalence of cognitive decline is expected to rise dramatically in the upcoming decades,  
 
predominantly due to demographic changes as well as increasing longevity (Moore, 2007).  
 
Therefore, understanding factors that may slow the rate of cognitive decline and provide some  
 
degree of protection against dementia, are of the utmost importance. This study examined the  
 
inter-relationships amongst LTPA, LTST, BMI and perceived cognitive functioning in younger  
 
and older Canadian adults. Overall, findings indicated that both younger and older individuals  
 
were generally overweight and inactive, no sex differences were observed. Results also showed  
 
that those who were more physically active and less sedentary reported better cognitive function  
 
and younger adults reported better perceived cognitive functioning compared to older adults. 
 
In younger adults, findings suggest that normal weight active and moderately active 
overweight active and moderately active, as well as obese active younger adults reported better 
perceived cognitive functioning scores. On the other hand, normal weight inactive, overweight 
inactive, and obese moderately active and inactive reported poorer perceived cognitive 
functioning scores. In older adults, normal weight active and overweight moderately active 
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reported better perceived cognitive functioning scores. Those who were normal weight 
moderately active, obese active as well as obese inactive reported poorer perceived cognitive 
functioning scores. However, obesity was associated with poorer perceived cognitive functioning 
scores in both younger and older adults as well as at all levels of PA. The poorer perception of 
cognitive functioning in individuals with obesity compared to normal weight may partly be 
explained by their increased disease risk, but other factors, such as negative perceptions of body 
weight, mild physical impairments and stigmatization may also play a role (Wilson, Latner & 
Hayashi, 2013).  
The findings of this study indicate that higher levels of physical activity, reduced 
sedentary time and a BMI in the normal weight or overweight range, may contributed to a better 
perception of cognitive function. LTPA is a modifiable behavioral factor that is often the focus 
of health promotion initiatives and physically active adults have slower rates of cognitive decline 
than those who are inactive
 
(Schuit, Feskens & Launer, 2001; Yaffe et al., 2001). Second, LTPA 
is independently related to disability and mortality, with estimates of 5-10% of deaths worldwide 
being due to physical inactivity
 
(WHO, 2002). The benefits of LTPA are numerous and well 
established. These include a reduction in the risk of cardiovascular disease, hypertension, stroke, 
type II diabetes, obesity, osteoporosis, some forms of cancer as well as improvements in aspects 
of mental health
 
(Haskell et al., 2007). LTPA has also been found to reduce functional 
limitations and delay cognitive decline
 
by increasing cardiovascular fitness and cerebral 
perfusion
 
(Nelson, Rejeski & Blair, 2007). On the other hand, a growing body of epidemiological 
evidence has linked sedentary behaviors to health risks including an increased risk of type II 
diabetes (Proper et al., 2011; Van Uffelen et al., 2010; Wilmot et al., 2012), metabolic syndrome 
(Edwardson et al., 2012), some cancers (Lynch, 2010), and all-cause and CVD mortality (Proper 
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et al., 2011; Van Uffelen et al., 2010; Wilmot et al., 2012). In terms of BMI, for middle-aged 
adults, higher BMI is associated with lower cognitive function and faster subsequent decline
 
(Cournot et al., 2006; Sabia et al., 2009). Cournot and colleagues (2006) found that a higher BMI 
was associated with lower cognitive scores after adjustment for age, sex, educational level, blood 
pressure, diabetes, and other psychosocial covariables (Cournot et al., 2006). In their study, 
higher BMI was also associated with a higher cognitive decline at follow-up, after adjustment for 
the confounding variables (Cournot et al., 2006). Thus, LTPA can be used as a tool to preserve 
cognitive functioning by way of reducing BMI and LTST.  
There are several strengths and limitations to our investigation. The use of a large 
nationally representative Canadian population dataset, making the study findings highly 
generalizable to the Canadian population and measuring perceived cognitive functioning in both 
younger and older adults, represent the strengths of this study. Nonetheless, because the CCHS is 
a cross-sectional study, these data do not allow us to determine causality in the LTPA, sedentary 
time, BMI and perceived cognitive functioning relationship. Second, reliance on self-reported 
LTPA, LTST and BMI might have resulted in underestimations of BMI and LTST and 
overestimations of LTPA. 
Conclusion 
People today are less active than they were decades ago (Church et al., 2011). LTPA and  
 
PA associated with work, home, and transportation has declined due to economic growth,  
 
technological advancements, and social changes. Along with this decrease in PA there has been  
 
an increase in sedentary activities leading to an increased prevalence of obesity (Juneau &  
 
Potvin, 2010). Due to these demographic changes, the prevalence of cognitive decline is  
 
expected to rise dramatically in the upcoming decades. Therefore, interventions that decrease the  
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risk of cognitive decline are critical. Increasing LTPA levels, reducing LTST and obesity are a  
 
few promising strategies that may contribute to a reduction in the prevalence of cognitive  
 
impairment.  
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Table 1-1: Characteristics of Participants in the Canadian Community Health Survey, 2012. 
Variable  30-59 years  60-80+ years 
 n=23 633 n=20 889 
Sex, Frequency (%)   
      Male 11018 (46.62)   8903 (42.62) 
      Female 12615 (53.38) 11983 (57.38) 
Marital Status, Frequency (%)   
      Married/Common-Law  15562 (65.85) 11565 (55.36) 
      Widowed/Separated/Divorced    3438 (14.55)   7882 (37.73) 
      Single/Never Married    4633 (19.60)   1442  (6.90) 
Education, Frequency (%)   
      Less than secondary school grad     2299 (10.04)   5712 (28.61) 
      Secondary school grad     4030 (17.60)   3433 (17.19) 
      Some post-secondary         903 (3.94)       715 (3.58) 
      Post-secondary grad   15671 (68.42) 10107 (50.62) 
BMI, Mean (SD)      27.09 (5.36)    27.01 (4.85) 
BMI, Frequency (%)   
      Normal Weight     9634 (40.77)   8015 (38.37) 
      Overweight     8305 (35.14)   8221 (39.36) 
      Obese     5694 (24.09)   4653 (22.27) 
Smoking, Frequency (%)   
       Yes   12893 (54.68) 11931 (57.28) 
       No    10684 (45.32)   8897 (42.72) 
High BP, Frequency (%)   
       Yes      3624 (15.38)   9465 (45.46) 
       No   19944 (84.62) 11357 (54.54) 
Diabetes, Frequency (%)   
       Yes     1205 (5.11)   3327 (15.94) 
       No   22395 (94.89) 17541 (84.06) 
Mood Disorder, Frequency (%)   
       Yes      2236 (9.48)    1405 (6.72) 
       No   21358 (90.52) 19441 (93.26) 
Physical Activity, Frequency (%)    
      Active     6355 (26.91)   4809 (23.05) 
      Moderately Active     6252 (26.47)   5096 (24.42) 
      Inactive   11010 (46.62) 10959 (52.53) 
Cognition Attribute of HUI,   
      Mean (SD) 
Sedentary Time, Frequency (%) 
       1.74 (1.12)      1.91 (1.17) 
      Low ST (<5-14 h) 
      Moderate ST (15-29 h) 
      High ST (30-45+ h) 
  10034 (42.46) 
    8250 (34.91) 
    5349 (22.63) 
  5394 (25.82) 
  7324 (35.07) 
  8170 (39.11) 
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Table 1-2: Mean Cognitive Functioning Scores Stratified by Socio-Demographics & Health History. 
Variable Mean (±SD) F-Value P-Value 
Age    
     Young (30-59y) 1.68 (0.060) 5.00 0.025 
      Old (60-80+y)  1.87 (0.060)   
Sex    
      Male 1.74 (0.061) 0.01 0.910 
      Female 1.75 (0.066)   
BMI    
      Normal Weight 1.75 (0.090) 0.72 0.486 
      Overweight 1.70 (0.060)   
      Obese 1.82 (0.077)   
PAI    
      Active 1.58 (0.078) 3.68 0.025 
      Moderately Active 1.70 (0.085)   
      Inactive 1.86 (0.067)   
Marital Status    
     Married/Common-Law 1.74 (0.055) 0.04 0.961 
     Widowed/Separated/Divorced 1.77 (0.107)   
     Single/Never Married 1.73 (0.110)   
Education    
      Less than secondary school grad 2.00 (0.097) 3.51 0.015 
      Secondary school grad 1.84 (0.100)   
      Some post-secondary 1.73 (0.183)   
      Post-secondary grad 1.65 (0.060)   
Sedentary Time (ST)    
      Low ST (<5-14 h) 1.74 (0.078) 1.05 0.349 
      Moderate ST (15-29 h) 1.68 (0.072)   
      High ST (30-45+ h) 1.83 (0.078)   
Smoking    
       Yes 1.79 (0.063) 0.83 0.362 
       No  1.71 (0.064)   
High BP    
       Yes  1.78 (0.067) 0.28 0.600 
       No 1.73 (0.055)   
Diabetes    
       Yes 1.80 (0.198) 0.08 0.774 
       No 1.74 (0.045)   
Mood Disorder    
       Yes 1.91 (0.194) 0.79 0.374 
       No 1.73 (0.046)   
*Physical Activity Post-Hoc Tests indicated significant differences between the active and inactive groups only (t=-2.69, 
p=0.007); Education Post-Hoc Tests indicated significant differences between those individuals with the lowest and the highest 
levels of education (t=3.13, p=0.002).  
All values are weighted. 
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Figure 2-1: Mean Cognitive Functioning Scores for Younger & Older Adults by Physical Activity Level 
& BMI Category. 
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Figure 2-2: Mean Cognitive Functioning Scores for Younger & Older Adults by Physical Activity Level, 
BMI Category & Sedentary Time. 
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Abstract 
 
Background: Excess adiposity is associated with impairments in cognitive functioning, whereas 
physical activity (PA) and fruit and vegetable consumption (FVC) may be protective against 
cognitive decline. Therefore, this study investigated the inter-relationships between FVC, BMI 
PA and perceived cognitive functioning in younger and older Canadian adults.  
Methods: Cross-sectional data of 45,522 participants (≥30y) were examined from the 2012 
annual component of the Canadian Community Health Survey. Perceived cognitive function was 
assessed using the cognitive attribute of the Health Utilities Index. PA was classified according 
to the Physical Activity Index; BMI was measured in kg/m
2
; FVC per day was classified as Low: 
<5; Moderate: 5-10, and; High: ≥10. To assess the inter-relationship between FVC, BMI, PA, 
age and perceived cognitive functioning, general linear models were used.  
Results: Higher BMIs, lower PA levels and a lower daily FVC contributed to worse cognitive 
functioning. This pattern persisted in younger and older adults (younger: µ=1.68±0.060, older: 
µ=1.87±0.060, p=0.03). As well, higher levels of education coupled with high daily FVC were 
associated with better perceived cognitive function (p<0.001). 
Conclusion: Independent of age, higher FVC and PA were associated with better perceived 
cognitive functioning.  
Key words: Physical activity, public health, food and nutrition 
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Background 
 
Dementia is a clinical syndrome that is characterized by a decline in intelligence,  
 
memory, and perception (Hedden & Gabrieli, 2004) 
 
as well as in logical and critical thinking,  
 
judgment and short-term memory
 
(Verhaeghen & Cerella, 2002). Non-modifiable risk factors for  
 
dementia include age and genetic susceptibility (Prince et al., 2013; Kramer & Erickson, 2007)
 
in  
 
addition to modifiable vascular risk factors (e.g. type II diabetes, hypertension, and smoking) and  
 
the presence of cardio- and cerebrovascular diseases. Several protective factors for cognitive  
 
decline have also been identified: these include attaining a high level of education as well as high  
 
work complexity, and having a rich social network
 
(Qiu et al., 2009). As well, from a primary  
 
prevention standpoint, engagement in physical activity (PA) is associated with reduced risk of a  
 
range of chronic conditions
 
(Qiu et al., 2010). For older adults there is a growing body of  
 
evidence that PA may delay the onset of cognitive decline and dementia (Kivipelto et al., 2005;  
 
Qiu et al., 2007; Middleton & Yaffe, 2009). PA is an important modifiable behavioral factor and  
 
is often the focus of health promotion initiatives. More recently, researchers have begun to focus  
 
on whether PA could also contribute to healthy brain ageing and this has prompted calls that it  
 
should be investigated more closely as a potential protective factor against cognitive decline and  
 
dementia
 
(Middleton & Yaffe, 2009). 
 
On the other hand, overweight and obesity increase the risk of cognitive decline  
 
independent of other comorbidities (Whitmer et al., 2005). For example, Cournot and colleagues  
 
(2006) found that a higher body mass index (BMI) was associated with lower cognitive scores  
 
after adjustment for age, sex, educational level, blood pressure, diabetes, and other psychosocial  
 
factors
 
(Cournot et al., 2006). Sabia and colleagues (2009) also found that both underweight and  
 
obesity were associated with poorer cognitive function
 
(Sabia et al., 2009). 
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Although excess weight may have unfavorable effects on cognitive health, healthy  
behaviors such as daily fruit and vegetable consumption (FVC), may serve to preserve cognitive  
integrity. FVC may influence the pathology of dementia in several different ways: fruits and  
vegetables both contain high quantities of a vitamin C, vitamin E, dietary fiber, flavonoids, β- 
carotenes as well as other classes of phytochemicals
 
(Vioque et al., 2008). These compounds  
exert their action via a host of different mechanisms; for instance, they can modulate detoxifying  
enzymes, stimulate the immune system, modulate cholesterol synthesis and act as antibacterial,  
antioxidant or neuroprotective agents
 
(Lampe, 1999). To date, very few studies have investigated  
the associations between FVC and cognitive decline
 
(Kuslansky et al., 2004, Ortega et al., 1997;  
Lee et al., 2001). Cross-sectional studies in Spain and Korea have shown that older adults with  
better cognitive performance consumed more servings of fruit and vegetables than older adults  
with impaired or poor cognitive performance
 
(Ortega et al., 1997; Lee et al., 2001). For the  
Korean participants, males and females with poor cognitive function had significantly lower  
intakes of fruits and vegetables than those individuals with normal cognitive scores on the  
MMSE (≥24, p<0.05) (Lee et al., 2001).  
Given existing patterns of inactivity and obesity, there is an increasing need to understand  
how modifiable risk factors for cognitive impairment may act to oppose or reinforce each other.  
Due to increasing life expectancy in industrialized countries and the increase in the prevalence of  
dementia (Ferri et al., 2005)
 
. Given these trends, there is a clear need to focus attention on  
strategies to preserve cognitive health. In contrast to the relative wealth of studies of  
cardiometabolic outcomes and mortality, less attention has been paid to the relationship between  
dietary patterns and cognitive outcomes in middle-aged and older people. Therefore, the aim of  
this study was to investigate the relationships that exist between FVC, BMI, PA and perceived  
cognitive functioning in younger (30-59y) and older (60-80+y) Canadian adults.  
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Methods 
Sample 
 
The 2012 annual component of the Canadian Community Health Survey (CCHS) was 
used in this study. It is a cross-sectional survey that collects information related to the health 
status of the Canadian population. The CCHS surveys a large sample of respondents and is 
designed to provide reliable estimates at the health region level. Using computer-assisted 
interviews, the CCHS recruits persons aged 12 and over living in private dwellings, representing 
98% of the Canadian population. Informed consent was obtained from each respondent by 
Statistics Canada. The present analysis was limited to respondents 30 years of age and older. 
Respondents with answers of “not stated” or “refused” for other study variables were excluded, 
leaving a sample of n = 45 522, with complete data for all study variables. This study was part of 
a larger project exploring the influence of different physical activity, anthropometric, and 
lifestyle variables on cognitive functioning in younger and older Canadian adults (See Chapter 2: 
Study 1).  
Measures 
 
Total Fruit and Vegetable Consumption: 
 
To determine total FVC, participants were asked how many servings of fruits and 
vegetables they consumed per day (<5, 5-10, and 10+). The measure assessing consumption of 
fruits and vegetables was established based on Canada’s Food Guide to Healthy Eating which 
was in use from 1992 to 2007. 
Physical Activity: 
 
Physical activity was assessed using an adaptation of the Minnesota Leisure Time 
Physical Activity Questionnaire
 
(Taylor et al., 1978). Respondents were asked about 
participation in 21 specified activities, plus up to three additional participant reported activities, 
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indicating participation frequency within the past 3 months as well as average session duration. 
Average daily energy expended during leisure time PA was calculated, weighting activities by 
their metabolic equivalent (MET) values, a measure of energy expenditure (Ainsworth et al., 
2000; Ainsworth et al., 2011). Results were expressed in kilocalories per kilogram per day 
(KKD). A Physical Activity Index categorized participants as active (≥3.0 KKD), moderately 
active (1.5–2.9 KKD), or inactive (<1.5 KKD). The CCHS Physical Activity Index demonstrates 
very good reliability (r=0.90) and validity when compared with physical activity measured by 
alternative questionnaire-based methods (r=0.77)
 
(Craig et al., 2002). 
            Anthropometry: 
BMI was calculated as kg/m
2
 from self-reported height and weight.  Participants were  
classified based on World Health Organization (WHO) guidelines as normal weight (18.5–24  
kg/m
2
), overweight (25–29.9 kg/m2), or obese (≥30 kg/m2) (WHO, 2002). 
Age: 
 
Age was self-reported as one of 16 possible categories. For the purposes of this analysis,  
 
only categories 6 (30-34 years of age) through 16 (80+ years of age) were analyzed. 
 
Perceived Cognitive Functioning: 
 
Perceived cognitive functioning was operationalized as a respondent’s score on the  
Cognition Attribute of Health Related Health Utilities Index (HUI)
 
(Patrick & Erickson, 1993).  
The HUI describes an individual’s functional health status using eight attributes: vision, hearing,  
speech, ambulation, dexterity, emotion, cognition, and pain. As well, it should be noted that  
correlations between the attributes in the HUI are very low thus each attribute contributes new  
information (Houle & Berthelot, 2000).The cognition attribute of the HUI has 6 levels of  
ability/disability, with level 1 indicating that individuals are able to remember most things, think  
clearly and solve day-to-day problems and level 6 indicating that individuals are unable to  
remember anything at all, and unable to think or solve day-to-day problems. Higher scores on the  
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cognition attribute indicate poorer levels of functioning. The HUI has strong test re-test  
reliability, validity and internal consistency (Cronbach’s α=0.81), and it is a very good  
discriminator of disease-related quality of life at the population level
 
(Horsman et al., 2003;  
Furlong et al., 2001). 
Covariates: 
 
Given their previously established relationships with the primary variables examined in 
these analyses, the following variables were considered as covariates: sex, marital status, 
education, smoking status, hypertension, diabetes, and mood disorder (Barnes et al., 2004; Marx, 
2005; Ngandu et al., 2007; Hayden et al., 2006; Goldstein et al., 2005; Barnes & Yaffe, 2011).  
Statistical Analysis 
 
Participants were categorized into younger/middle aged (30-59years) and older adult 
(60+ years) groups. Categorical variables are presented as frequencies and percentages, and 
continuous variables as means and standard deviations (SD). 
The relationships between BMI, PA, daily FVC and perceived cognitive functioning 
scores in younger/middle aged and older Canadian adults were explored. General linear models 
were used to determine the associations between the variables of interest, after adjusting for 
covariates. As well, because the effect of education was significant, it was included in the final 
model. Regression diagnostics were assessed; there were no influential outliers and residuals 
were normally distributed. Because the interactions between PA, BMI, daily FVC, cognitive 
functioning scores and age were significant (p<0.001), analyses were further stratified by age.  
Statistical analyses were performed using SAS v9.4 (SAS Institute Inc., NC, USA) with  
 
statistical significance set at an α of 0.05. To ensure representativeness of the results to the  
 
Canadian population, data were weighted using the master weight in SAS survey procedures. 
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Results 
 
The demographic and health characteristics of the sample are presented in Table 1. Study  
 
participants were on average overweight (younger: µ=27.09±5.36; Older: µ=27.01±4.85), with  
 
about 59% of the younger adult population and 62% of the older adult population overweight or  
 
obese. Nearly 47% of the younger adults and 53% of the older adults were inactive, whereas only  
 
27% of younger adults and 23% of older adults were active. Approximately 61% of younger  
 
adults and 59% of older adults reported a FVC of less than 5 servings per day; whereas, 39% of  
 
younger adults and 41% of older adults reported a daily FVC of more than 5 servings. Finally,  
 
68% of younger adults and 51% of older adults were post-secondary graduates, whereas 32% of  
 
younger adults and 49% of older adults had not obtained a post-secondary school education.   
 
As presented in Table 2, individuals who reported higher PA levels reported better  
 
perceived cognitive functioning compared to those who were moderately active or inactive  
 
(Active: µ=1.58±0.078; Moderately Active: µ=1.70±0.085; Inactive: µ=1.86±0.067; p=0.03).  
 
Younger adults reported better perceived cognitive functioning compared to older adults  
 
(Younger: µ=1.68±0.060; Older: µ=1.87±0.060; p=0.03). In regards to BMI, those who were  
 
normal-weight and overweight reported better perceived cognitive functioning than individuals  
 
with obesity. In terms of FVC, participants who consumed 10 or more servings had the best  
 
perceived cognitive functioning scores (<5: 1.75±0.058; 5 to 10: 1.68±0.078, and; 10+:  
 
1.46±0.172).  As well, individuals with higher levels of education reported better perceived  
 
cognitive functioning scores than those with lower levels of education (Less than secondary  
 
school grad: 2.00±0.097; secondary school grad: 1.84±0.100; some post-secondary: 1.73±0.183;  
 
post-secondary grad: 1.65±0.060). Also, individuals who were married/common-law, non- 
 
smokers, and were otherwise healthy (i.e. non-diabetic, normotensive, and no reported mood  
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disorder) reported better perceived cognitive functioning than individuals who were  
 
single/divorced/widowed, smokers, diabetics, hypertensive, and those who reported having a  
 
mood disorder.  
 
Individuals who were normal-weight or overweight and reported a FVC of more than 10  
 
servings per day reported better perceived cognitive functioning scores than those who reported  
 
fewer than 10 servings, as well as those individuals with obesity (Figure 1a). As well, both  
 
active and inactive individuals who reported a FVC of more than 10 servings per day had better  
 
perceived cognitive scores than those who consumed fewer servings. However, in those who  
 
were moderately active, individuals with a daily FVC of less than 5 or 5-10 servings, reported  
 
better perceived cognitive functioning than those with a daily FVC of 10 or more servings; this  
 
may have resulted because of underestimations of the number of servings of fruits and vegetables  
 
actually consumed (Figure 1b). 
 
Due to the significant interaction with age, analyses were stratified into younger adults  
 
and older adults. Younger adults with a daily FVC of more than 10 servings generally reported  
 
better perceived cognitive functioning scores at every BMI-category and PA-level than those  
 
who consumed fewer servings (Figure 2). Furthermore, those who reported consuming 5-10  
 
servings had better cognitive scores than those who consumed less than 5 servings. Older adults,  
 
with a daily FVC of more than 10 servings, generally reported better perceived cognitive  
 
functioning. Finally, overweight and obese older adults with a daily FVC of less than 5 servings  
 
generally reported poorer perceived cognitive functioning scores.  
 
Higher levels of education contributed to better perceived cognitive functioning scores.  
 
Findings indicate that individuals with a post-secondary education with a daily FVC of five or  
 
more servings reported better perceived cognitive functioning scores; conversely, those  
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individuals who are normal-weight/inactive, overweight/inactive, and obese/inactive with a daily  
 
FVC of less than 5 servings reported poorer perceived cognitive functioning scores. As well,  
 
regardless of level of PA, individuals with higher levels of education who were normal-weight  
 
and overweight reported better perceived cognitive functioning than obese adults (Figure 3).  
 
Discussion 
Main Finding of this study 
This study examined the inter-relationship between PA, total daily FVC, BMI and  
 
perceived cognitive functioning in younger and older Canadian adults. Overall, the prevalence of  
 
overweight and inactivity was high amongst both younger and older men. As expected, younger  
 
adults reported better cognitive functioning scores than older adults. Additionally, analyses  
 
revealed that individuals with a higher daily FVC and PA level, who were normal-weight or  
 
overweight, with higher levels of education reported better perceived cognitive functioning  
 
scores.  
 
What is already Know on this topic 
 
 Currently, it is known that diets which are high in fruits and vegetables are widely  
 
recommended due to their health promoting properties. FVC has been strongly associated with  
 
reduced risk of cardiovascular disease (CVD), cancer, diabetes, and age-related functional  
 
decline (Temple, 2000; Willet, 1994). Currently, the association between FVC and cognitive  
 
function remains unclear, as very little research exists in this area
 
(Kuslansky et al., 2004, Ortega  
 
et al., 1997; Lee et al., 2001).
 
As well, although much work has been done to explore the  
 
relationship between PA on cognitive function, this relationship has been mainly explored in  
 
older adults
 
(Qiu et al., 2010; Qiu et al., 2007; Kivipelto et al., 2005; Middleton & Yaffe, 2009).  
 
To date, very little is known about the inter-relationships between PA and FVC and perceived  
 
cognitive function, in both younger and older adults. 
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What this study adds 
 
The findings of this study show that PA, FVC, and BMI in both younger and older adults  
 
impact perceived cognitive functioning. The results of this study indicate that younger adults  
 
with a daily FVC of 10 or more servings reported better perceived cognitive functioning scores  
 
at every BMI category irrespective of PA level. In older adults, however, those with a daily FVC  
 
of at least 5 daily servings generally reported better cognitive functioning scores, a relationship  
 
that also varied by BMI and PA. Excess adiposity, declining PA levels, as well as nutrition  
 
transition (the trend towards increased consumption of a diet high in saturated fat, sugar, and low  
 
in fiber) among communities are the top risk factors for morbidity and mortality worldwide
31
.  
 
Therefore, PA, BMI and FVC are important modifiable factors that can affect the maintenance of  
 
the healthy aging phenotype. Successful cognitive aging combines multiple cognitive domains,  
 
such as memory and executive functioning; this definition also encompasses the link between  
 
cognitive health with functional independence
 
(Lim et al., 2012).  Thus, increasing FVC and PA  
 
levels as well as having a healthy BMI, may aid in the delay of cognitive decline. 
 
Results also indicated that higher levels of education along with a daily FVC of 5 or more  
 
servings contributed to better perceived cognitive functioning. Education may be assisting in the  
 
process of delaying cognitive decline be increasing cognitive reserve, the ability of the human  
 
brain to cope with damage by using different brain processes to retain the ability to function  
 
well. Cognitive reserve is developed through intellectual stimulation and translates into a higher  
 
volume of connections between neurons and stronger rates of cerebral blood flow
 
(Mathers,  
 
2013) .  
 
The results of this study indicate that higher levels of physical activity, a higher daily  
 
intake of fruits and vegetables, as well as being normal weight or overweight might contribute to  
65 
 
 
better perceived cognitive functioning. The benefits of regular PA are well documented in the  
 
clinical and public health literature and include reduced risk of many chronic diseases, stress and  
 
depression, and increased emotional well-being, energy level, self-confidence and satisfaction  
 
with social activity
 
(Hakansson et al., 2009). Physically inactive people are more likely to be  
 
obese, which itself is an important risk factor for many chronic diseases
 
(Brown et al. 2007;  
 
Warburton et al., 2006). Therefore, regular PA engagement along with a daily FVC of more than  
 
5 servings and a healthy BMI may be beneficial to preserving cognitive integrity and delaying  
 
cognitive decline. If the onset of dementia can be delayed by 5 years, there would be a reduction  
 
in over a million cases after 10 years, and over 4 million cases after 50 years
 
(Middleton &  
 
Yaffe, 2009).  Thus, identifying potential strategies for the maintenance of cognitive health has  
 
considerable public health benefit. 
 
Limitations of this study 
 
This investigation was aimed at elucidating the inter-relationships between PA, BMI,  
 
FVC, and perceived cognitive functioning scores in younger and older Canadian adults. There  
 
are several strengths and limitations to our investigation. The strengths of our study include  
 
studying both younger and older adults, the use of a nationally representative Canadian dataset,  
 
the application of survey weights to ensure the findings are generalizable to the population, as  
 
well as adjustment for known confounding variables
 
(Warburton et al., 2006; Costet et al., 1998).  
 
Nonetheless, because the CCHS is a cross-sectional study, no causal effects can be inferred. As  
 
well, reliance on self-reported PA, total FVC and BMI may have resulted in underestimations of  
 
BMI and overestimations of PA and total FVC. 
 
Conclusion 
Ageing is described as a continuous process that includes loss of functional capability as  
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well as the increase in risk of morbidity and mortality
 
(Wang et al., 1999). Although ageing is a  
 
risk factor for chronic diseases, it is not necessarily defined by the presence of morbidities but is  
 
instead a process that starts early in life, which is modulated by the accumulation of experiences  
 
and exposures throughout the life-course
 
(Franco et al., 2009). Although life expectancy has  
 
increased in the past few decades, the years lived with disabilities and diseases are increasing
  
 
(Salmon et al., 2012), and the prevalence of cognitive decline is expected to rise dramatically in  
 
the upcoming decades, predominantly due to demographic changes as well as increasing  
 
longevity.  Therefore, identifying effective ways to delay the onset of cognitive decline is of  
 
great importance (Brookmeyer et al., 2007). The extent to which engagement in regular PA,  
 
daily FVC, and weight maintenance are sufficient to provide clinically meaningful reductions in  
 
the rate of cognitive decline is not yet known, and requires a longitudinal study in order to more  
 
fully explore the dose-dependent nature of these relationships. 
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Table 2-1: Characteristics of Participants in the Canadian Community Health Survey, 2012. 
Variable  30-59 years  60-80+ years 
 n=23 633 n=20 889 
Sex, Frequency (%)   
      Male 11018 (46.62)   8903 (42.62) 
      Female 12615 (53.38) 11983 (57.38) 
Marital Status, Frequency (%)   
      Married/Common-Law  15562 (65.85) 11565 (55.36) 
      Widowed/Separated/Divorced    3438 (14.55)   7882 (37.73) 
      Single/Never Married    4633 (19.60)   1442  (6.90) 
Education, Frequency (%)   
      Less than secondary school grad     2299 (10.04)   5712 (28.61) 
      Secondary school grad     4030 (17.60)   3433 (17.19) 
      Some post-secondary         903 (3.94)       715 (3.58) 
      Post-secondary grad   15671 (68.42) 10107 (50.62) 
BMI, Mean (SD)      27.09 (5.36)    27.01 (4.85) 
BMI, Frequency (%)   
      Normal Weight     9634 (40.77)   8015 (38.37) 
      Overweight     8305 (35.14)   8221 (39.36) 
      Obese     5694 (24.09)   4653 (22.27) 
Smoking, Frequency (%)   
       Yes   12893 (54.68) 11931 (57.28) 
       No    10684 (45.32)   8897 (42.72) 
High Blood Pressure, Frequency (%)   
       Yes      3624 (15.38)   9465 (45.46) 
       No   19944 (84.62) 11357 (54.54) 
Diabetes, Frequency (%)   
       Yes     1205 (5.11)   3327 (15.94) 
       No   22395 (94.89) 17541 (84.06) 
Mood Disorder, Frequency (%)   
       Yes      2236 (9.48)    1405 (6.72) 
       No   21358 (90.52) 19441 (93.26) 
Physical Activity, Frequency (%)    
      Active     6355 (26.91)   4809 (23.05) 
      Moderately Active     6252 (26.47)   5096 (24.42) 
      Inactive   11010 (46.62) 10959 (52.53) 
Cognition Attribute of HUI,   
      Mean (SD) 
Total Fruit/Vegetable Consumption, 
Frequency (%) 
       1.74 (1.12)      1.91 (1.17) 
      Less than 5 
      5 to 10 
      10 or more 
  13783 (60.77) 
    8090 (35.67) 
    1760  (3.56) 
  11313 (59.03) 
    7345 (38.33) 
      506  (2.64) 
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Table 2-2: Mean Cognitive Functioning Scores Stratified by Socio-Demographics & Health History. 
Variable Mean (±SE) F-Value P-Value 
Age    
     Young (30-59y) 1.68 (0.060) 5.00    0.03 
      Old (60-80+y)  1.87 (0.060)   
Sex    
      Male 1.74 (0.061) 0.01    0.91 
      Female 1.75 (0.066)   
BMI    
      Normal Weight 1.75 (0.090) 0.72    0.49 
      Overweight 1.70 (0.060)   
      Obese 1.82 (0.077)   
PAI    
      Active 1.58 (0.078) 3.68    0.03 
      Moderately Active 1.70 (0.085)   
      Inactive 1.86 (0.067)   
Marital Status    
     Married/Common-Law 1.74 (0.055) 0.04    0.96 
     
Widowed/Separated/Divorced 
1.77 (0.107)   
     Single/Never Married 1.73 (0.110)   
Education    
      Less than secondary 
school grad 
2.00 (0.097) 3.51    0.02 
      Secondary school grad 1.84 (0.100)   
      Some post-secondary 1.73 (0.183)   
      Post-secondary grad 1.65 (0.060)   
Total Fruit/Vegetable 
Consumption 
   
      Low (Less Than 5) 1.75 (0.058) 1.44     0.24 
      Moderate (5 to 10) 1.68 (0.078)   
      High (10 or more) 1.46 (0.172)   
Smoking    
       Yes 1.79 (0.063) 0.83     0.36 
       No  1.71 (0.064)   
High Blood Pressure    
       Yes  1.78 (0.067) 0.28     0.60 
       No 1.73 (0.055)   
Diabetes    
       Yes 1.80 (0.198) 0.08     0.77 
       No 1.74 (0.045)   
Mood Disorder    
       Yes 1.91 (0.194) 0.79     0.37 
       No 1.73 (0.046)   
 
All values are weighted. 
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Abbreviations: FV: fruits and vegetables; NW: normal weight; OW: overweight; OB: obese; M. Active: moderately active. 
Figure 3-1: Mean cognitive functioning scores by BMI & total daily fruit and vegetable consumption and 
PA level and total daily fruit and vegetable consumption. 
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Abbreviations: FV: fruits and vegetables; NW: normal weight; OW: overweight; OB: obese; A: active; MA: moderately active; IA: inactive.  
Figure 3-2: Mean Cognitive Functioning Scores by BMI Category and PA level for Younger and Older 
Adults: Total Daily Fruit and Vegetable Consumption. 
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Abbreviations: FV: fruits and vegetables; NW: normal weight; OW: overweight; OB: obese; A: active; MA: moderately active; IA: inactive.  
Figure 3-3: Mean Cognitive Functioning Scores by BMI/PA Category & Fruit/Vegetable Consumption: 
Level of Education. 
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Abstract 
 
Background: Prescription medication use is on the rise and the rates of cognitive decline are  
 
also expected to increase dramatically due to the ageing of the world’s population. Given that the  
 
treatment options for Alzheimer’s and dementia are limited, efforts to identify means of  
 
cognitive preservation are essential. 
 
Purpose: The aim of this study was to explore the relationships between established risk factors  
 
(physical activity, medication use (number of medications taken), obesity (waist-to-hip ratio),  
 
age) and cognitive function (measured as episodic memory and executive function). 
 
Methods: This study used data from the Midlife in the U.S. (MIDUS) a national longitudinal  
 
study of health and well-being as people age from early adulthood into midlife and old age. The  
 
inter-relationships between moderate to vigorous physical activity (MVPA), waist-to-hip ratio  
 
(WHR), medication use, and cognitive functioning were explored using ANCOVAs and general  
 
linear models after adjusting for covariates. 
 
Results: Engagement in regular MVPA has a protective effect on cognitive function irrespective  
 
of the number of medications taken. However, lower levels of physical activity, higher  
 
medication use and WHR correspond with worse cognitive function scores (p<0.001); this  
 
relationship became more pronounced with age. 
 
Conclusions: Regular engagement in physical activity may contribute to the preservation of  
 
cognitive performance as well as countering the adverse effects of prescription medication taken  
 
for chronic conditions, across the lifespan. 
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Introduction 
 
Age related cognitive decline is an escalating worldwide public health concern (Prince et  
 
al., 2013). Cognitive functioning reflects the series of psychological processes involved  
 
in the acquisition, organization and application of knowledge. It includes short-term and long- 
 
term memory, attention and language (Verhaeghen & Cerella, 2002). Moreover, complex  
 
cognitive tasks depend on a set of executive functions (goal oriented behaviors such as  
 
problem solving, multitasking, and plan making)
 
(Verhaeghen & Cerella, 2002).  Evidence  
 
points to executive functioning impairments as contributors to declines in cognitive functioning  
 
that may result in a Mild Cognitive Impairment (MCI; cognitive problems that exceed the normal  
 
declines associated with aging but are not severe enough to meet the criteria for the diagnosis of  
 
dementia) or a dementia spectrum disorder
 
(Bishop, Lu &Yankner, 2010; Hedden & Gabrieli,  
 
2004). The prevalence of dementia is expected to rise dramatically in the coming decades,  
 
predominantly due to demographic changes and increasing longevity (Moore, 2007).  
 
Currently, there is no cure for cognitive decline or dementia, and pharmaceutical therapies  
 
have limitations in compliance due to adverse side effects and cost (Moore, 2007), for this reason  
 
other means of disease prevention or delay of disease onset are essential. 
 
Cognitive decline may be exacerbated by cardiovascular risk factors (e.g., hypertension,  
 
type II diabetes, high cholesterol, overweight/obesity). As well, excess body weight is a global 
health problem, with more than 60% of the US and Canadian adult populations classified as 
overweight or obese. With numbers as high as these, if any of the above exert even a small 
adverse effect on cognitive abilities, it might have a detrimental effect on public health (Hedley 
et al., 2004). Impairments in attention, executive function (“higher level” cognitive functions 
involved in control and regulation of “lower level” cognitive processes and goal oriented and 
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future oriented behaviors), and processing speed are common with cognitive decline (Cohen et 
al., 2009; Roberts et al., 2014; Yaffe et al., 2014). As well as, reduced episodic memory, episodic 
memories allow people to mentally travel back in time to an event from the recent or distant past; 
episodic memories include various details about these events, such as what happened, when it 
happened and where it happened, is also observed (Yaffe et al., 2014; Almaeida et al., 2012). 
Data from cross-sectional studies are reinforced by longitudinal analyses showing accelerated 
cognitive decline in individuals with type II diabetes, high blood pressure and high cholesterol 
within the domains of executive function and episodic memory (Dregan et al., 2013; Okonkwo et 
al., 2010). Cardiovascular risk factors have also been associated with reduced brain volume, 
decreased white matter integrity, and reductions in cerebral blood flow (Beason-Held et al., 
2012). Moreover, structural and functional brain alterations associated with cardiovascular risk 
factors induce predictable cognitive impairments such as deficits in episodic memory and 
executive dysfunction (Alosco et al., 2013). 
Physical activity plays an important role in reducing vascular risk factors, including  
  
blood pressure and total cholesterol (Kumari & Heese, 2010). As well, the chances of diabetes  
 
and insulin resistance are reduced and inflammatory elements in the blood appear to be lowered  
 
(Joyner & Green, 2009; Biessels et al., 2006). Only recently, however, have investigators  
 
realized that physical activity also offers protection against cognitive decline and dementia, with  
 
an inverse correlation between the amount of exercise a person engages in and the possibility of  
 
experiencing cognitive decline. Studies have reported that people who regularly exercise have  
 
faster reaction times than those who do not, are able to discriminate between multiple stimuli  
 
better and can outperform those who are not physically active on tasks involving reasoning,  
 
working memory, and fluid intelligence tests (Abbott et al., 2004; Sun et al., 2010). As a whole, 
 
80 
 
cardiovascular risk factors negatively impact cognitive performance whereas physical activity  
 
may offer protection against cognitive decline. 
 
Research indicates that certain classes of hypertension medication negatively affect  
 
cognition (e.g., beta-blockers) (Amenta et al., 2002; Muldoon et al., 2002; Murray et al., 2002).  
 
However, most of the research to date has been conducted on younger rather than older samples.  
 
As well, a drug interaction between metformin (a drug often used in individuals with type II  
 
diabetes) and the cubilin receptor inhibits the uptake of vitamin B12 thus lowering serum vitamin  
 
B12 levels. And reduced B12 levels are associated with neuropathy (Wile & Toth, 2010). Given  
 
the high prevalence of chronic conditions such as type II diabetes, hypertension and high  
 
cholesterol and the substantial evidence of the adverse impact of these conditions on cognition, it  
 
is somewhat surprising that the treatment status of these conditions is not regularly considered in  
 
the psychological literature on cognitive ageing. Individuals who have been diagnosed with  
 
hypertension, type II diabetes, and high cholesterol are on medications for years or even decades  
 
and though the literature on the adverse effects of these conditions on health is vast (Okonko et  
 
al., 210; Nwankno et al., 2013; Roberts et al., 2014). Currently, not much is known about the  
 
impact of medication use and whether as the number of medications used increases, cognitive  
 
performance declines. Therefore, the aim of this study is to explore the relationships between  
 
physical activity, obesity, medication use (number of medications taken), age and cognitive  
 
function. 
Methods 
 
This study used data from the Midlife in the U.S. survey (MIDUS; Brim, Ryff, &  
 
Kessler, 2004), a national longitudinal study of factors (behavioral, social, psychological,  
biological, neurological) influencing health and well-being as people age from early adulthood  
into midlife and old age. In 1995, MIDUS survey data were collected from a total of 7,108  
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participants. All eligible participants were non-institutionalized English speaking adults in the  
contiguous United States, aged 25-74 years. Respondents were asked to participate in a phone  
interview of approximately 30 minutes in length and complete 2 self-administered  
questionnaires. With funding provided by the National Institute on Aging, a longitudinal follow- 
up of MIDUS I began in 2004, with an added cognitive function component. Of the 7,108 in  
MIDUS I, 4,963 were successfully contacted to participate in MIDUS II. Separate ethics  
approval was not required, as the data were accessed using the Inter University Consortium for  
Political and Social Research (ICPSR), of which York University is an institutional member  
(http://www.icpsr.umich.edu/icpsrweb/landing.jsp).  
Physical Activity 
Physical activity was measured with 4 items assessing the participant's frequency of 
vigorous and moderate physical activity in the summer and winter months on a 6-point scale (1 =  
Several times a week or more, 2 = About once a week, 3 = Several times a month, 4 = About  
once a month, 5 = Less than once a month, 6 = Never): “During the summer, how often do you  
engage in vigorous physical activity (e.g. running or lifting heavy objects) long enough to work  
up a sweat?”, “What about during the winter - how often do you engage in vigorous physical  
activity enough to work up a sweat?”, “During the summer, how often do you engage in  
moderate physical activity (e.g. bowling or using a vacuum cleaner)?”, “What about during the  
winter - how often do you engage in moderate physical activity?”. The differences between  
physical activity intensities were assessed separately for the winter and summer months and no  
significant differences were observed between seasons. Therefore, a new variable was created  
called MVPA (moderate to vigorous physical activity) with response options of “often”  
“sometimes,” or “rarely”. Individuals who reported engaging in physical activity “several times  
per week or more” were categorized into the “often” group; those who reported physical activity  
engagement “about once per week” or “several times per month” were categorized into the  
“sometimes” group, and; those who reported physical activity engagement “about once a month”  
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or “less than once a month” or “never” were categorized into the “rarely” group. 
Cognitive Function 
Cognitive functioning was tested using the Brief Test of Adult Cognition by Telephone  
(BTACT) (Tun & Lachman, 2006). The BTACT provides a brief battery for telephone  
assessment of key domains of cognitive function, including episodic memory (memory of  
experiences and specific events in time in serial form), working memory span (the number of  
items, usually words or numbers, that a person can retain or recall), executive function (goal  
oriented behaviors such as problem solving, multitasking, and plan making), reasoning and speed  
of processing (the ability to process information automatically and quickly, without intentional  
thinking through), using tests that are sensitive to performance in community-dwelling adults  
ranging from young to middle-aged and older. The BTACT is administered in <20 minutes, is  
easily scored and provides a composite measure of cognitive function. The BTACT composite  
score showed good internal consistency of α =0.82 (Tun & Lachman, 2006) and includes the  
following tests: 
 two measures of episodic memory (immediate and delayed free recall of 15 words); 
 
 attention switching and inhibitory control (the Stop and Go Switch Task); 
 
 processing speed (the number of digits produced by counting backward from 100 in 30 
seconds); 
 
 working memory span (backward digit span—the highest span achieved in repeating 
strings of digits in reverse order); 
 
 inductive reasoning (completing a pattern in a series of 5 numbers); 
 
 verbal fluency (the number of words produced from the category of animals in 60 
seconds).  
 
Two factor scores episodic memory and executive function were calculated using the seven  
tests. Tests of immediate and delayed recall were used to calculate episodic memory and the  
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remainders of the tests were used to calculate executive function (Tun & Lachman, 2006).  
Medication Use 
Number of medications used was assessed using a series of questions regarding diagnosis  
of and treatment for hypertension, high cholesterol, and type II diabetes. A new variable was  
created called “number of medications used” (no medications, 1 medication, 2-3 medications). 
Age 
Participants were asked to indicate the year of their birth which was then subtracted from the 
year that the interview was conducted. Subsequently, respondents were categorized into 4 
groups: 25-44 years, 45-54 years, 55-64 years, 65-84 years. 
Anthropometry 
Participants were mailed a tape measure and asked to measure their waist circumference  
at the level of the navel to the nearest ¼ inch and hip circumference measurements were to be  
taken at the widest point. Waist-to-hip ratio (WHR) has been suggested to be superior to body  
mass index (BMI) in predicting metabolic syndrome and cardiovascular diseases (Janssen et al.,  
2004). WHR was subsequently classified as “healthy” (M: <0.95; F: <0.80) or “unhealthy” (M:  
≥0.95; F: ≥0.80). 
Covariates 
Sex, marital status (married, separated/divorced/widowed, never married), level of 
education (some grade school-some high school, GED-graduated high school, some college/no 
bachelor’s degree, college grad-doctorate/professional degree), and ethnicity/race (White or 
Non-White (African American, native American, Asian, native Hawaiian, pacific islander, 
other)) were adjusted for in the analyses. Respondents with answers of ‘‘not stated’’ or 
‘‘refused’’ for other study variables were excluded. 
Statistical Analysis 
The final sample consisted only of participants who had participated in both MIDUS and  
completed the cognitive function measures. The inter-relationships between MVPA, obesity,  
84 
 
medication use, and cognitive functioning were explored using ANCOVAs and general linear  
models after adjusting for covariates. Individual Z-scores for the cognitive measures of  
executive function and episodic memory were used in the data analysis (Tun & Lachman, 2006).  
Because the interactions between MVPA, obesity, medication use, cognitive functioning scores  
and age were significant (p<0.001), analyses were further stratified by age. Statistical analyses  
were performed using SAS v 9.4 (SAS Institute Inc., NC, USA) with statistical significance set  
at an α of 0.05. 
Results 
 
Over 46% of the sample reported that they rarely/never engage in moderate-to-vigorous 
physical activity (MVPA), whereas 12% reported engaging in MVPA sometimes, and 42% of 
the sample reporting that they engage in MVPA regularly/often. As well, 27% of males and 23% 
of females reported a healthy WHR, whereas 18% of males and 32% of females reported an 
elevated WHR. Approximately 22% of the sample also reported taking 1 medication and 12% 
reported taking 2-3 medications (Table 1). 
Younger adults reported better scores on both measures of cognitive function than older 
adults; executive function (25-44 years (Mean Z-Score, SD): 0.51 (0.88), 45-54 years: 0.27 
(0.89), 55-64 years: -0.03 (0.94), 65-84 years: -0.61 (0.92)) and episodic memory (25-44 years: 
0.40 (0.94), 45-54 years: 0.18 (0.92), 55-64 years: 0.01 (0.95), 65-84 years: -0.49 (0.98)). 
Individuals who engaged in MVPA often or sometimes reported better cognitive functioning 
scores on both executive function (MVPA (often): 0.27 (0.91), MVPA (sometimes): 0.12 (0.95), 
MVPA (never): -0.24 (0.99)) and episodic memory (MVPA (often): 0.17 (0.99), MVPA 
(sometimes): 0.12 (1.06), MVPA (never): -0.14 (0.97)) than those who engaged in MVPA 
rarely/never. As well, with regards to medication use, individuals who are taking fewer 
medications reported better cognitive function; executive function (no medication: 0.14 (1.01), 1 
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medication: -0.19 (0.97), 2-3 medications: -0.34 (0.87)) and episodic memory (no medication: 
0.10 (0.99), 1 medication: -0.12 (1.01), 2-3 medications: -0.27 (0.96)). Finally, males and 
females with a healthy WHR reported better cognitive function, on both executive function and 
episodic memory measures, than males and females with an elevated WHR (Table 2). 
Figure 1 illustrates the relationships between the individual variables of interest and the 
cognitive function outcomes (executive function and episodic memory). Findings generally 
indicate that individuals who engage in MVPA often or sometimes, are younger, and are on 
fewer medications, report better scores on both executive function and episodic memory 
measures. 
Figure 2 displays the inter-relationships between MVPA, age category, medication use 
and cognitive function. With regard to executive function, individuals who consumed no 
medications for type II diabetes, hypertension, or high cholesterol reported better scores than 
individuals who consumed 1 or 2-3 medications. Furthermore, individuals who reported 
engaging in MVPA often or sometimes had better scores than those who engaged in MVPA 
rarely. As well, scores declined with age, and the decline was more pronounced in individuals 
who were less active and consumed more medications (Figure 2). Similar findings were 
observed with episodic memory (Figure 3). Once again, individuals who consumed no 
medications for type II diabetes, hypertension, or high cholesterol reported better scores than 
individuals who consumed 1 or 2-3 medications. The decline in scores became more pronounced 
with increasing age and lower levels of MVPA. 
The inter-relationships between MVPA, medication use, WHR, age and both cognitive 
function measures indicate that as people age engaging in MVPA often or sometimes as well as 
having a healthy WHR may offer protection against cognitive decline and preserve both 
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executive function (Table 3) and episodic memory (Table 4). On the other hand, taking a greater 
number of medications was associated with worse cognitive function.  
Discussion 
This study explored the relationships between MVPA, medication use, WHR, and age. 
The findings of this study indicate that lower levels of physical activity and higher WHR and 
number of medications used corresponded with worse cognitive function scores on both 
executive function and episodic memory measures; this relationship was consistent with age.  
Prolonged use of one or multiple medications and the accumulation of their side effects  
as well as interactions may have negative consequences for cognitive functioning (Mirowsky &  
Ross, 2003). The findings of this study indicate that physical activity may counter some of the  
adverse effects of medication use and offer protection against cognitive decline. Physical activity  
may preserve cognitive function by way of improving cerebral circulation by increasing the  
blood flow and oxygen supply to the brain (Kivipelto et al., 2005). Regular physical activity  
lowers blood pressure and lipids, prevents metabolic syndrome, has a positive effect on  
inflammatory markers and improves endothelial function, all of which are risk factors for  
cardiovascular diseases and dementia (Kivipelto et al., 2005). Animal studies indicate that  
physical activity stimulates neuron proliferation in hippocampal regions (Hillman et al., 2008),  
and may even increase hippocampal volume in humans (Erickson et al., 2011). As well, the  
findings of this study indicate that MVPA at all ages may offer protection against cognitive  
decline and perhaps even counteract some of the adverse effects of medications used to treat type  
II diabetes, high blood pressure and high cholesterol. Additionally, significant differences were  
observed between individuals who engaged in MVPA regularly and consumed fewer  
medications versus those who engaged in MVPA rarely or never and consumed 1 and 2-3  
medications on both measures of executive function and episodic memory; with individuals who  
engaged in MVPA more often and consumed fewer medications reporting better scores. 
87 
 
The prevalence of cognitive decline and dementia as well as prescription drug use are on  
the rise. Hypertension affects 70 million American adults and nearly 7.5 million Canadians  
(Nwankwo et al., 2013; Genest et al., 2009); nearly 29.1 million Americans and 3.4 million  
Canadians have diabetes (Centers for Disease Control and Prevention, 2014; Public Health  
Agency of Canada, 2011); and finally, high cholesterol affects 71 million Americans (33.5%)  
and 39% of Canadians (Centers for Disease Control and Prevention, 2011; Kappelle et al., 2012).  
Currently, nearly 60% of Americans taking prescription medication (Kantor & colleagues,  
2015); indeed, almost 3 in 5 American adults take a prescription drug, up markedly since 2000.  
The most commonly used drugs being those for the treatment of high cholesterol, high blood  
pressure and type II diabetes (Kantor et al., 2015). The rise in the use of prescription medication  
might reflect the growing need for treatment of complications associated with the increase in  
overweight, obesity and a sedentary lifestyle and a decline in physical activity levels, and this  
elevation might in turn contribute to the increasing prevalence of cognitive decline. 
 This study has several strengths that should be noted. First, this is the first study to  
explore the relationship between the number of medications taken and the corresponding impact  
on cognitive function scores. Other strengths include the use of a large dataset exploring age- 
related variations in health and well-being across the lifespan; as well as, evaluating cognitive  
performance using both episodic memory and executive function measures. However, this study  
is not without its limitations. For example, it is unknown how long participants have been using  
prescription medication and which prescription medications they were on. Additionally, since it  
is unclear which medications were used, it is possible that more than 3 medications were being  
used and the number of medications used  actually represents the number of chronic conditions  
an individual has. As well, due to the self-report nature of the data there may have been  
overestimations in physical activity and underestimations in the waist and hip circumference  
measures that were used to calculate WHR. 
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Conclusion 
 
As the world’s population grows older, the prevalence rates of both cognitive decline and  
 
prescription medication use are on the rise. Although ageing is a risk factor for chronic diseases,  
 
ageing is not necessarily defined by the presence of morbidities but as a process that starts early  
 
in life and is modulated by the accumulation of experiences and exposures throughout the life- 
 
course (Franco et al., 2009). Although life expectancy has increased in the past few decades, the  
 
years lived with disabilities and diseases are increasing (Salomon et al., 2012). Therefore,  
 
identifying effective ways to delay the onset of dementia is of great importance for alleviating  
 
the family and societal pressures of this syndrome (Brookmeyer et al., 2007). Physical activity  
 
may be useful means of preserving cognitive performance by countering the effects of  
 
prescription medication taken for chronic conditions, across the lifespan. 
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Table 3-1: Demographic Characteristics of The Midlife in the U.S. Survey (MIDUS). 
 
 
 
 
Variable  
 N=4 153 
Age (Mean, SD) 55.99 (12.34) 
Age Categories (Freq, %)  
     1 (25-44 years)   857 (20.64) 
     2 (45-54 years) 1125 (27.09) 
     3 (55-64 years) 1058 (25.48) 
     4 (65-84 years) 1113 (26.80) 
Sex (Freq, %)  
     Male 1904 (45.85) 
     Female 2249 (54.15) 
Waist-to-Hip Ratio (Freq, %)  
     1 (Male, <0.95) 1074 (26.84) 
     2 (Male, ≥0.95)   737 (18.42) 
     3 (Female, <0.80)   925 (23.11) 
     4 (Female, ≥0.80) 1266 (31.63) 
Marital Status (Freq, %)  
     1 (Married) 2978 (71.71) 
     2 (Separated/ Divorced/  
          Widowed) 
  731 (17.60) 
     3 (Never Married)   444 (10.69) 
Education (Freq, %)  
     1 (Some Grade School- Some  
         High School) 
  261 (6.30) 
     2 (GED-Graduated High School) 1151 (27.76) 
     3 (Some College/No Bachelors  
        Degree)  
1243 (29.98) 
     4 (College Grad- 
         Doctorate/Professional  
         Degree) 
1491 (35.96) 
Race (Freq, %)  
     1 (White) 3819 (91.96) 
     2 (African American, Native  
         American, Asian, Native 
         Hawaiian/Pacific Islander,  
         Other) 
  334 (8.04) 
Number of Meds Used (RX Use) (Freq, %)  
    0 2697 (64.94) 
    1   931 (22.42) 
    2+   525 (12.64) 
MVPA (Freq, %)  
    1 (Often) 1514 (41.50) 
    2 (Sometimes)   452 (12.39) 
    3 (Never) 1682 (46.11) 
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Table 3-2: Mean Cognitive Function Scores. 
Variable Executive Function 
(Mean, SD) 
Episodic Memory (Mean, 
SD) 
Sex    
      Male  0.13 (1.00) -0.24 (0.91) 
      Female -0.10 (0.99)   0.21 (1.02) 
Waist-To-Hip-Ratio   
      Male (<0.95)  0.18 (1.00) -0.20 (0.92) 
      Male (≥0.95)  0.06 (0.99) -0.29 (0.90) 
      Female (<0.80) -0.02 (1.04)  0.26 (1.00) 
      Female (≥0.80) -0.16 (0.94)  0.16 (1.01) 
Age   
     1(25-44 years)  0.51 (0.88)  0.40 (0.94) 
     2(45-54 years)  0.27 (0.89)  0.18 (0.92) 
     3(55-64 years) -0.03 (0.94)  0.01 (0.95) 
     4(65-84 years) -0.61 (0.92) -0.49 (0.98) 
Race   
     1(White)  0.04 (0.99)  0.02 (1.00) 
     2(African American, 
         Native American,   
        Asian, Native    
        Hawaiian/Pacific 
        Islander, Other) 
-0.40 (0.98) -0.24 (0.98) 
Education   
     1(Some Grade School- 
         Some High School) 
-0.92 (0.91) -0.55 (0.94) 
     2(GED-Graduated  
         High School) 
-0.36 (0.90) -0.18 (0.95) 
     3(Some College/No 
         Bachelors Degree) 
-0.05 (0.89)  0.02 (1.01) 
     4(College Grad-     
      Doctorate/Professional  
      Degree) 
 0.49 (0.92)  0.22 (0.97) 
Marital Status   
     1(Married)  0.03 (0.98)  0.01 (0.99) 
     2(Separated/ Divorced/  
          Widowed) 
-0.28 (1.02) -0.15 (1.01) 
     3(Never Married)  0.33 (0.97)  0.16 (1.01) 
Number of Meds Used   
     0  0.14 (1.01)  0.10 (0.99) 
     1 -0.19 (0.97) -0.12 (1.01) 
     2-3 -0.34 (0.87) -0.27 (0.96) 
MVPA    
     1(Often)  0.27 (0.91)  0.17 (0.99) 
     2(Sometimes)  0.12 (0.95)  0.12 (1.06) 
     3(Never) -0.24 (0.99) -0.14 (0.97) 
 
95 
 
Table 3-3: Differences in Executive Function by Medication Use, MVPA, WHR & Age. 
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
Table 3-4: Differences in Episodic Memory by Medication Use, MVPA, WHR & Age. 
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Figure 4-1: Relationships between individual variables of interest and cognitive function outcome 
variables. 
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Significant Differences: No medication: 25-44 years: MVPA(often) vs. MVPA(rarely) p<0.0001; MVPA(sometimes) vs. MVPA(rarely) p=0.001. 45-
54 years: MVPA(often) vs. MVPA(rarely) p<0.0001; MVPA(sometimes) vs. MVPA(rarely) p=0.0052. 55-64 years: MVPA(often) vs. MVPA(rarely) 
p<0.0001; MVPA(often) vs. MVPA(sometimes)    p=0.0013. 65-84 years: MVPA(often) vs. MVPA(rarely) p<0.0001.  One medication: 45-54 years: 
MVPA(often) vs. MVPA(rarely) p=0.0339; 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0019; 65-84 years: MVPA(often) vs. MVPA(rarely)  
p<0.0001. 2-3  Medications: 65-84 years: MVPA(often) vs. MVPA(sometimes)  p<0.0162. 
Effect size (ω2; 95% Confidence Interval): 0.22; 0.19, 0.24). 
 
Figure 4-2: Executive function scores by medication use, level of physical activity and age. 
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Significant Differences: No medication: 25-44 years: MVPA(often) vs. MVPA(rarely) p=0.0147;  45-54 years: MVPA(often)  vs. MVPA(rarely) 
p=0.0063; 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0028.  One medication: 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0306; 
MVPA(sometimes) vs. MVPA(rarely)  p=0.0433; 65-84 years: MVPA(often) vs. MVPA(rarely)  p=0.0424; MVPA(sometimes) vs. MVPA(rarely)  
p=0.0462.  
       Effect size (ω2; 95% Confidence Interval): 0.17; 0.15, 0.19). 
 
Figure 4-3: Episodic memory scores by medication use, level of physical activity and age. 
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Abstract 
 
Background: Finding lifestyle variables that may preserve cognitive function or delay the onset  
 
of cognitive decline are of the utmost importance. Especially because the prevalence of cognitive  
 
decline continues to rise and effective treatment options remain elusive.  
 
Purpose: The aim of this study was to explore the inter-relationships between physical activity  
 
(frequency, intensity, season), cognitive stimulation (reading, attending lectures, card games,  
 
word games), obesity (waist-to-hip ratio), age, and cognitive function (measured as episodic  
 
memory and executive function).  
 
Methods: This study used data from the Midlife in the United States (MIDUS) national  
 
longitudinal survey conducted in 1995/1996 and 2004/2005. The inter-relationships between  
 
physical activity, obesity, cognitive stimulation, and cognitive functioning were explored using  
 
general linear models. 
 
Results: Both executive function and episodic memory scores declined with age. However, at all  
 
ages, individuals who engaged in moderate to vigorous physical activity often or sometimes and  
 
regularly engaged in cognitively stimulating activities reported less cognitive decline (p<0.001). 
 
Conclusions: The cumulative effects of physical activity and cognitive stimulation appear to be  
 
effective means for maintaining cognitive function as well as reducing the risk for cognitive  
 
decline, at every age group. 
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Introduction 
 
Dementia is a neurological condition involving global impairment of cognitive ability  
 
that interferes with normal activities and everyday functioning, with notable deficits in a person's  
 
episodic (short-term) memory and executive functioning, the cognitive processes involved in  
 
planning and organization of one’s resources in pursuit of a goal (Budson & Price, 2005). In  
 
2010, there were an estimated 36 million people living with dementia and with increasing life  
 
expectancy, these numbers are expected to reach 66 million in 2030 and 115 million by 2050  
 
(World Health Organization, 2012). Therefore, identifying early intervention opportunities to  
 
offset the risk of cognitive decline is a public health priority. Factors that may protect against  
 
cognitive decline include moderate-to-vigorous physical activity (MVPA) (Laurin et al., 2001;  
 
Abbott et al., 2004) and cognitively stimulating activities such as reading, learning a new skill or  
 
partaking in a new activity, or playing card or word games (Kramer et al., 2004). 
 
Despite the well-known benefits of MVPA, physical activity levels tend to decrease, and  
 
the prevalence of overweight and obesity tends to increase, with age, which may exacerbate  
 
existing difficulties in normal functioning and instrumental activities of daily life (Kostic et al.,  
 
2011). Indeed, frontal lobe functions, particularly executive ability, tend to deteriorate  
 
disproportionately with age, and may be improved with a regular program of walking (Abbott et  
 
al., 2004). The Canadian Study of Health and Aging, a large-scale population-based study of  
 
individuals 65 years and older, also found that higher levels of MVPA were associated with  
 
reduced risk of cognitive impairment, Alzheimer’s disease, and dementia of any type (Laurin et  
 
al., 2001). 
 
Evidence suggests that complex mental activities and learning can also offer protection  
 
against cognitive decline; thus, higher levels of education, occupational complexity, and higher  
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IQ all offer protection against cognitive decline (Valenzuela & Sachdev, 2005). As well, leading  
 
a mentally active lifestyle (e.g., learning a new language or playing card games) has been shown  
 
to positively influence cognitive functioning (Hultsch et al., 1999; Kramer et al., 2004; Wilson et  
 
al., 2002).  Thus, participation in cognitively stimulating leisure activities (i.e. reading) may be  
 
effective means by which to preserve cognitive function and delay cognitive decline.  
 
 It is known that both physical activity and cognitive stimulation individually exert  
 
positive effects on cognitive function. However, the combined effects and relative importance of  
 
each is not well understood, and it is currently unclear whether there are critical time points  
 
from early adulthood into midlife and old age for optimal benefit. Therefore, the aim of this  
 
study was to explore the inter-relationships between physical activity, cognitive stimulation (i.e.  
 
reading, attending lectures/courses, playing cards games, playing word games), obesity, age, and  
 
cognitive function in adults between the ages of 25 to 84 years of age.  
 
Methods 
 
The present study used data from the Midlife in the United States (MIDUS; Brim, Ryff,  
 
& Kessler, 2004) national longitudinal survey conducted in 1995/1996 and 2004/2005. MIDUS  
was designed to explore the role of various behavioral, social, psychological, biological, and  
neurological factors  in physical and mental health as people age. It was based on a nationally  
representative sample (random-digit-dial) of non-institutionalized, English-speaking adults aged  
25 to 74 (wave I) years, selected from working telephone banks in the contiguous United States  
in 1995. With support from the National Institute on Aging, a longitudinal follow-up (wave II,  
which took place 10 years later) of the original MIDUS national probability sample was  
conducted in 2005 and included a cognitive function component (Ryff et al., 2012)  
Data were obtained using the Inter University Consortium for Political and Social  
Research (ICPSR), of which York University is an institutional member  
(http://www.icpsr.umich.edu/icpsrweb/landing.jsp) and a separate ethics approval was not  
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required. This study was part of a larger project exploring the influence of different physical  
activity, anthropometric, and lifestyle variables on cognitive functioning in younger, middle- 
aged, and older Canadian adults (See Chapter 4: Study 3). 
Physical Activity 
 An index of physical activity was derived from items that assessed frequency, intensity  
(vigorous, moderate) and season (summer, winter). First, participants were asked: “How  
often do you engage in vigorous PA that causes your heart to beat so rapidly that you can feel it  
in your chest and you perform the activity long enough to work up a good sweat and to breath  
heavily?” This question was asked and answered twice (once for summer and once for winter).  
Second, participants were asked: “How often do you engage in moderate PA, that is not  
physically exhausting, but it causes your heart rate to increase slightly and you typically  
work up a sweat?” This question was also asked and answered twice (once for summer and once  
for winter). After examining the differences between PA intensities and seasons, no significant  
differences were observed between the winter and summer months, allowing for moderate and  
vigorous physical activity (MVPA) information to be pooled and categorized as “often”  
“sometimes,” or “rarely”. Individuals who answered “several times per week or more” were  
categorized into the “often” group; those who answered “about once per week” or “several times  
per month” were categorized into the “sometimes” group and; those who responded “about once  
a month,” “less than once a month,” or “never” were categorized into the “rarely/never” group. 
Cognitive Stimulation 
Participants were asked about frequency of engagement in mental activities such as 
reading, doing word games, playing cards, and attending lectures. Each participant indicated the  
frequency of engaging in these activities using a 6-point ordinal scale ranging from 1 (daily) to 6  
(never) (Lachman et al., 2011). A new variable was created called cognitive stimulation with  
response options of “regularly” or “sometimes,” on the basis of participation in these activities.  
Individuals who reported engaging in any of these activities “daily” were categorized into the  
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“regularly” group, and everyone else was categorized in to the “sometimes” group. 
Cognitive Function 
Cognitive function was measured using the Brief Test of Adult Cognition by Telephone  
(BTACT), a neuropsychological battery of six cognitive tests, including measures of episodic  
verbal memory (Word List Immediate and Delayed), working memory span (Digits Backward),  
verbal fluency (Category Fluency), inductive reasoning (Number Series), and processing speed  
(Backward Counting) (Tun & Lachman, 2006). Participants also completed the Stop and Go  
Switch Task testing their attention switching and inhibitory control (Tun & Lachman, 2008).  
Two factor scores, episodic memory (EM) and executive function (EF), were derived using the  
seven cognitive tests (Lachman et al., 2011).  
Anthropometry 
 
Waist-to-hip ratio (WHR) was measured as the ratio of waist to hip circumference.  
 
Participants were asked to measure their waist circumference at the level of the navel and hip  
 
circumference at the widest point, using a tape measure that was mailed to them. WHR is often  
 
used as a crude estimate of body fat distribution, with elevated WHR defined as ≥0.80 and ≥0.95  
 
in women and men, respectively. 
 
Covariates 
 
Marital status (married, separated/divorced/ widowed, never married), sex, level of 
education (some grade school-some high school, GED-graduated high school, some college/no 
bachelor’s degree, college grad-doctorate/professional degree), and ethnicity (White or non-
White (African American, native American, Asian, native Hawaiian, pacific islander, other)) 
were treated as potential confounders and adjusted for in all analyses. Respondents with answers 
of ‘‘not stated’’ or ‘‘refused’’ for other study variables were excluded. 
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Statistical Analysis 
Participants were classified into four separate groups on the basis of their age (25-44  
years of age, 45-54 years of age, 55-64 years of age, and 65-84 years of age). The final sample  
was comprised solely of individuals who had completed MIDUS I, MIDUS II, and the cognitive  
 
component. Participants’ Z-scores for episodic memory and executive function were used in the  
 
data analysis. The inter-relationships between MVPA, obesity, cognitive stimulation, and  
 
cognitive functioning were explored using general linear models and ANCOVAs after adjusting  
 
for covariates. Because the interactions between MVPA, obesity, cognitive stimulation, cognitive  
 
functioning scores and age were significant (p<0.001), analyses were further stratified by age. 
 
Statistical analyses were performed using SAS v 9.4 (SAS Institute Inc., NC, USA) with 
 
statistical significance set at an α of 0.05. 
 
Results 
 
About 42% of the sample indicated they engaged in regular MVPA often, 12% of the  
 
sample reported engaging in MVPA sometimes, and 46% of the sample reported engaging in  
 
MVPA rarely/never. As well, nearly 72% of the sample reported engaging in cognitively  
 
stimulating activities regularly (i.e. reading, attending courses/lectures, playing card games,  
 
playing word games), and approximately 29% of the sample reported engaging in cognitively  
 
stimulating activities sometimes (Table 1). 
 
 With regards to executive function, z-scores appear to decline with age. Older adults  
 
reported worse scores than younger adults (25-44 years (mean z-score, SD): 0.51 (0.88), 45-54  
 
years: 0.27 (0.89), 55-64 years: -0.03 (0.94), 65-84 years: -0.61 (0.92)). As well, individuals who  
 
engaged in MVPA often or sometimes reported better scores compared to those who engaged in  
 
MVPA rarely/never (MVPA (often):  0.27 (0.91), MVPA (sometimes): 0.12 (0.95), MVPA  
 
(never): -0.24 (0.99)). Also, individuals with a healthy WHR (both males and females) reported  
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better scores (males: 0.18 (1.00), females: -0.02 (1.04)) than those with an unhealthy WHR  
 
(males: 0.06 (0.99), females: -0.16 (0.94)). Finally, individuals who reported regular engagement  
 
in cognitively stimulating activities reported better executive function scores compared to those  
 
individuals who only engaged in these activities sometimes (regularly: 0.06 (0.97), sometimes:- 
 
0.10 (1.02)) (Table 2). 
  
Similarly, episodic memory scores also declined with age (25-44 years: 0.40 (0.94), 45- 
 
54 years: 0.18 (0.92), 55-64 years: 0.01 (0.95), 65-84 years: -0.49 (0.98)) (Table 2). As  
 
expected, those who engaged in (MVPA (often): 0.17 (0.99), MVPA (sometimes): 0.12 (1.06),  
 
MVPA (never): -0.14 (0.97)) and had a healthy WHR reported better episodic memory scores  
 
(healthy WHR males: -0.20 (0.92), females: 0.26 (1.00)), than those with an elevated WHR  
 
(unhealthy WHR males: -0.29 (0.90), females: 0.16 (1.01)). Finally, those individuals who  
 
engaged in cognitively stimulating activities regularly also reported better scores than those who  
 
engaged in these activities only sometimes (males: 0.03 (1.01), females: -0.03 (0.98)). 
 
Engaging in cognitively stimulating activities regularly contributed to better scores on  
 
both cognitive function measures (executive function: 0.06; episodic memory 0.03) than  
 
engaging in cognitively stimulating activities sometimes (executive function: -0.1; episodic  
 
memory -0.03) (Figure 1). Further, regular engagement in cognitively stimulating activities  
 
contributes to superior scores on both executive function and episodic memory measures and this  
 
relationship became more pronounced with age. Individuals who engaged in these activities  
 
often reported better scores and lower levels of decline in comparison to individuals who only  
 
engaged in these activities sometimes (Figure 2). Finally, individuals who engaged in  
 
cognitively stimulating activities often and participated in MVPA regularly (often or sometimes)  
 
reported better cognitive functioning than those who engaged in cognitively stimulating activities  
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sometimes and MVPA rarely (Figure 3). 
 
Figure 4 illustrates the inter-relationship between MVPA, cognitive stimulation, age, and  
 
executive function. Findings indicate that regular/frequent engagement in cognitively stimulating  
 
activities along with regular engagement in MVPA (often or sometimes) may contribute to  
 
superior executive functioning, a relationship that became more pronounced with age. 
 
Figure 5 illustrates the inter-relationship between MVPA, cognitive stimulation, age, and  
 
episodic memory. Similar to executive function, regular/frequent engagement in cognitively  
 
stimulating activities along with regular engagement in MVPA (often or sometimes) may  
 
contribute to better episodic memory. This relationship became more pronounced with age. 
 
Discussion 
 
This study examined the relationships between MVPA, cognitive stimulation, obesity,  
 
age and cognitive function. Results indicated that engaging in cognitively stimulating  
 
activities along with regular MVPA, results in better cognitive functioning scores on both  
 
executive function and episodic memory in every age group. However, in this study, elevated  
 
WHR was not related to poorer cognitive function. 
 
Research to date suggests that ageing is associated with declines in cognitive functioning  
 
and brain structural changes. In particular, life-span studies have reported cognitive decline in  
 
both executive functions and episodic memory (especially delayed recall) (Keys & White, 2000;  
 
Luo & Craik, 2008; Salthouse, 2009). Results from the present study indicate that although  
 
episodic memory and executive functioning decline with age, the decline is less pronounced in  
 
individuals who lead physically and cognitively active lifestyles. Specifically, in all age groups,  
 
individuals who regularly or sometimes engaged in MVPA and cognitively stimulating activities  
 
regularly. In the absence of a cure, preventing or delaying the onset of dementia is a critical  
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public health priority. Among the mechanisms proposed, brain reserve, the ability to withstand  
 
damage and continue to function normally, may be increased by way of MVPA (Raz &  
 
Lindenberger, 2005). Normal ageing is associated with global volumetric shrinkage in brain  
 
structures (i.e. hippocampus, prefrontal areas) leading to potential adverse consequences on  
 
cognitive functioning (Raz & Lindenberger, 2005). Brain reserve has been most commonly used  
 
to provide an explanation describing a subset of individuals who, at autopsy, have the hallmarks  
 
of Alzheimer’s disease including amyloid plaques and yet during their life did not show clinical  
 
symptom manifestations of the disease (Snowden, 2003). The incongruity between having  
 
extensive brain neuropathology without cognitive impairment has contributed to the belief that a  
 
larger brain volume, larger neurons, and more synaptic connections can act as a buffer, or  
 
protective factor in preventing or slowing down cognitive decline.  
  
Cognitive reserve, on the other hand, which involves active compensation, can be  
 
increased by regular engagement in cognitively stimulating activities. One potential strategy that  
 
has been noted in functional imaging studies is that prefrontal activity during cognitive  
 
performance tends to be less localized, to the right or left side of the brain specifically, in older  
 
compared to younger adults (Cabeza & Anderson, 2002). This indicates that the ageing brain,  
 
uses more of its resources in an attempt to compensate for both structural and functional decline.  
 
Brain reserve and cognitive reserve are two parallel processes that help to explain that there is  
 
more than one pathway to maintaining cognitive health as people age from early adulthood into  
 
midlife and old age. 
 
This study aimed to build on previous research by exploring lifestyle means that may  
 
preserve cognitive function at various stages of life, ranging from early adulthood into midlife  
 
and old age. Exploring a wider age range is a key strength of this work because most of the  
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existing literature is focused on older adults. Other strengths include the use of a large dataset  
 
focused specifically on variables that influence health and using a valid and reliable tool to  
 
measure cognitive function. Nonetheless, the limitations of this study include overestimations of  
 
physical activity and underestimations of both waist and hip circumference measures that were  
 
used to calculate WHR, which may have occurred due to the self-report nature of the data.  
 
Conclusion 
  
The findings of this study indicate that those who engage in moderate-to-vigorous  
 
physical activity and cognitively stimulating activities have superior episodic memory and  
 
executive function, a trend that becomes more pronounced with age. Due to the ageing of the  
 
population and the relative scarcity of effective treatment options for cognitive decline, cognitive  
 
health will have an increasing impact on the health and independence of older adults. Thus,  
 
interventions that determine lifelong strategies to delay or even prevent cognitive decline and  
 
dementia are imperative. 
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Table 4-1: Demographic Characteristics of the Midlife in the U.S. Survey (MIDUS). 
 
 
Variable  
 N=4 153 
Age (Mean, SD) 55.99 (12.34) 
Age Categories (Freq, %)  
     25-44 years   857 (20.64) 
     45-54 years 1125 (27.09) 
     55-64 years 1058 (25.48) 
     65-84 years 1113 (26.80) 
Sex (Freq, %)  
     Male 1904 (45.85) 
     Female 2249 (54.15) 
Waist-to-Hip Ratio (Freq, %)  
     Healthy Male, <0.95 1074 (26.84) 
     Elevated Male, ≥0.95   737 (18.42) 
     Healthy Female, <0.80   925 (23.11) 
     Elevated Female, ≥0.80 1266 (31.63) 
Marital Status (Freq, %)  
     Married 2978 (71.71) 
     Separated/ Divorced/Widowed)   731 (17.60) 
     Never Married   444 (10.69) 
Education (Freq, %)  
     Some Grade School- Some  
     High School 
    261 (6.30) 
     GED-Graduated High School 1151 (27.76) 
     Some College/No Bachelors Degree  1243 (29.98) 
     College Grad-Doctorate/ Professional  
     Degree 
1491 (35.96) 
Race (Freq, %)  
     White 3819 (91.96) 
      Non-White   334 (8.04) 
Cognitive Stimulation (Freq, %)  
    Regularly   2610 (71.55) 
    Sometimes   1038 (28.45) 
MVPA (Freq, %)  
    Regularly/Often 1514 (41.50) 
    Sometimes   452 (12.39) 
    Rarely/Never 1682 (46.11) 
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Table 4-2: Mean cognitive functioning scores. 
Variable Executive Function 
(Mean, SD) 
Episodic Memory  
(Mean, SD) 
Sex    
    Male  0.13 (1.00) -0.24 (0.91) 
    Female -0.10 (0.99)  0.21 (1.02) 
Waist-To-Hip-Ratio   
     Healthy Male, <0.95  0.18 (1.00) -0.20 (0.92) 
     Elevated Male, ≥0.95  0.06 (0.99) -0.29 (0.90) 
     Healthy Female, <0.80 -0.02 (1.04)  0.26 (1.00) 
     Elevated Female, ≥0.80 -0.16 (0.94)  0.16 (1.01) 
Age   
    25-44 years  0.51 (0.88)  0.40 (0.94) 
    45-54 years  0.27 (0.89)  0.18 (0.92) 
    55-64 years -0.03 (0.94)  0.01 (0.95) 
    65-84 years -0.61 (0.92) -0.49 (0.98) 
Race   
    White  0.04 (0.99)  0.02 (1.00) 
    Non-White -0.40 (0.98) -0.24 (0.98) 
Education   
     Some Grade School-    
     Some High School 
-0.92 (0.91) -0.55 (0.94) 
     GED-Graduated   
     High School 
-0.36 (0.90) -0.18 (0.95) 
     Some College/No  
     Bachelors Degree 
-0.05 (0.89)  0.02 (1.01) 
     College Grad  
     Doctorate/   
     Professional Degree 
 0.49 (0.92)  0.22 (0.97) 
Marital Status   
     Married  0.03 (0.98)  0.01 (0.99) 
     Separated/ Divorced/  
     Widowed 
-0.28 (1.02) -0.15 (1.01) 
     Never Married  0.33 (0.97) 0.16 (1.01) 
Cognitive Stimulation   
   Regularly  0.06 (0.97)   0.03 (1.01) 
   Sometimes -0.10 (1.02)  -0.03 (0.98) 
MVPA   
    Regularly/Often  0.27 (0.91)  0.17 (1.00) 
    Sometimes  0.12 (0.95)  0.12 (1.06) 
    Rarely/Never -0.24 (0.99) -0.14 (0.97) 
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Figure 5-1: Relationship between cognitive stimulation participation frequency and cognitive function. 
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Figure 5-2: Cognitive stimulation frequency and cognitive function scores in different age groups. 
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Figure 5-3: Cognitive stimulation frequency and cognitive function scores at different levels of MVPA. 
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Significant Differences: Cognitive Stimulation Regularly: 25-44 years: MVPA(often) vs. MVPA(rarely) p=0.0030; MVPA(sometimes) vs. MVPA(rarely) 
p=0.001. 45-54 years: MVPA(often)   vs. MVPA(rarely) p=0.0014; MVPA(sometimes) vs. MVPA(rarely) p=0.0131. 55-64 years: MVPA(often) vs. 
MVPA(rarely) p<0.0001; MVPA(often) vs. MVPA(sometimes)  p=0.0037. 65-84 years: MVPA(often) vs. MVPA(rarely) p<0.0001;  MVPA(sometimes) 
vs. MVPA(rarely) p=0.0117.  Cognitive Stimulation Sometimes: 25-44 years: MVPA(often) vs. MVPA(rarely) p=<0.0001; MVPA(sometimes) vs. 
MVPA(rarely) p=0.0052. 45-54 years: MVPA(often) vs. MVPA(rarely) p=0.0406; 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0024; 
MVPA(sometimes) vs. MVPA(rarely) p=0.0444.  65-84 years: MVPA(often) vs. MVPA(rarely)  p=0.0092.  
Effect size (ω2; 95% Confidence Interval): 0.22; 0.20, 0.24). 
 
Figure 5-4: Cognitive stimulation frequency and executive function scores at different levels of MVPA and 
different age groups. 
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Significant Differences: Cognitive Stimulation Regularly: 45-54 years: MVPA(often)   vs. MVPA(rarely) p=0.0161; MVPA(sometimes) vs. MVPA(rarely) 
p=0.0131. 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0033; MVPA(sometimes) vs. MVPA(rarely)  p=0.0100. 65-84 years: MVPA(often) vs. 
MVPA(rarely) p<0.0001 p=0.0253.  Cognitive Stimulation Sometimes: 25-44 years: MVPA(often) vs. MVPA(rarely) p=0.0116; MVPA(sometimes) vs. 
MVPA(rarely) p=0.0052. 55-64 years: MVPA(often) vs. MVPA(rarely) p=0.0443. 
Effect size (ω2; 95% Confidence Interval): 0.11; 0.10, 0.13). 
 
Figure 5-5: Cognitive stimulation frequency and episodic memory scores at different levels of MVPA and 
different age groups. 
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CHAPTER 6: GENERAL DISCUSSION 
 
There are several important reasons for the increasing relevance of studying,  
 
understanding and working to preserve cognitive health. A hundred years ago, the leading causes  
 
of death were infectious diseases, with approximately 40% of people unable to survive beyond  
 
childhood (Fogel, 2005). However, with access to clean drinking water, and improvements in the  
 
practices targeting both prevention and treatment of infectious diseases, the leading causes of  
 
death have been dramatically altered. Today, people are living longer, and in developed regions,  
 
there has been a marked shift towards more age-related causes of death. In the past several  
 
decades, brain illnesses, dementias in particular, have begun to increase as the leading causes of  
 
mortality (Steenland et al., 2009). Indeed, the prevalence of cognitive decline and dementia is  
 
expected to rise dramatically over the coming decades due to demographic changes and  
 
increasing longevity (Moore, 2007). At the present time, there is a much larger inventory of  
 
treatment strategies for cardiovascular conditions than there are for cognitive decline.  
 
Levels of physical activity in all facets of life (i.e. work, leisure/recreational,  
transportation) have declined over the past century (Church et al., 2011; Mirowsky & Ross,  
2010; Wyatt & Hecker, 2006). Along with these decreasing levels of physical activity,  
simultaneous decreases in the consumption of fruits and vegetables and increases in food intake  
and the prevalence obesity have been observed (Kessler, 2009; Cook & Deponte, 2008). As well,  
a great number of individuals spend many of their early adult and middle-age years (prior to  
reaching old age) living with severe problems controlling their blood glucose levels, cholesterol  
and blood pressure (Bray & Bellanger, 2006; Centers for Disease Control and Prevention, 2010;  
Duncan et al., 2004; Ford et al., 2004; Mensah et al., 2004). On a population level, medical  
interventions have not been able and probably will not be able to eliminate the adverse  
physiological consequences of physical inactivity throughout the lifespan; and these  
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accumulating adverse physiological effects will eventually contribute to the degradation of  
cognitive performance (Grodstein et al., 2001; Morley, 2004; Cournot et al., 2006; Sabia et al.,  
2009). Thus, identifying effective strategies for preservation of cognitive health in older age are  
important. Therefore, the four projects composing this dissertation are modeled in such a way  
that the existing inter-relationships between cognitive function, physical activity and other  
lifestyle and health variables can be evaluated at various points during the lifespan. This model  
insinuates that at every stage of life, cognitive health is determined by complex interactions  
between physical activity, lifestyle factors, anthropometry, and age.  
This project explored the following lifestyle variables: sedentary time, daily fruit and  
vegetable consumption, the number of medication used, and engagement in cognitively  
stimulating activities; BMI and WHR were the anthropometric measures used; finally, age  
groups were categorized as younger versus older and as younger, middle aged and older  
adulthood (Figure 1). The conceptual model that was implemented in this project informs us of  
 
the existing inter-relationships between various lifestyle variables and cognitive function. What it  
 
does not inform us of is the factors that might contribute to behavior change in the population.  
 
The next logical step would be to implement or develop a model that does. 
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Figure 6-1: General theoretical model illustrating the potential relationships between lifestyle, 
Anthropometry, physical activity and cognitive health, across the lifespan. 
Summary of Key Findings 
 
 The first study explored the inter-relationships between physical activity, sedentary time,  
obesity, and cognitive function in younger and older Canadian adults using data from the 2012  
annual component of the Canadian Community Health Survey (CCHS); including only  
respondents 30 years of age and older  with complete data for all study variables. The findings of  
this study indicate that lower levels of physical activity, along with higher BMIs and higher  
sedentary times contribute to poor cognitive functioning scores; a relationship that was found to  
become more pronounced with age.  
Study two, using the same data set as study one, evaluated the associations between  
physical activity, daily fruit and vegetable consumption, obesity, and cognitive function in  
younger and older Canadian adults. The results of this study indicate that lower levels of physical  
activity, along with lower daily fruit and vegetable consumption and higher BMI, contribute to  
poorer cognitive function scores.  
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 Study three examined the relationships between moderate to vigorous physical activity  
(MVPA) engagement frequency, obesity, number of medications used (for type II diabetes, high  
blood pressure, and high cholesterol), and cognitive function in individuals between the ages of  
25-84 years. This study used data from the Midlife in the U.S. Survey (MIDUS), which evaluates  
health and well-being as people age from early adulthood into midlife and old age. The findings  
of this study indicate that regular engagement in MVPA may offer some protection against, or at  
the very least, slow the rate of cognitive decline. However, as people age, and risk factors  
accumulate, cognitive function worsens on both episodic memory and executive function  
measures. 
 Last, study four, using the same data set as study three, investigated the inter- 
relationships between MVPA engagement frequency, obesity, cognitive stimulation (reading,  
attending lectures/courses, playing card games, playing word games), and cognitive function in  
individuals between the ages of 25-84 years. The findings of this study indicate that regular  
engagement in MVPA and cognitively stimulating activities contribute to the preservation of  
cognitive functions. This relationship persists with age and was observed on both measures of  
episodic memory and executive functions. Obesity did not influence this relationship in this  
study. 
Interestingly, no sex differences were found in any of the performed studies. This was  
surprising and there are no clear explanations for this finding. It may have been the result of the  
self-report nature of the datasets that were used or due to the unique makeup of the samples in  
these studies (e.g., they were healthier and more highly educated sample then previous samples).  
Additionally, the lack of sex differences may be because both younger and older adults were  
studied, and perhaps when looking across the life span sex is not the most important variable that  
contributes to differences in cognitive performance and physical activity, lifestyle variables,  
education, and anthropometrics all play a bigger role. However, these explanations are entirely  
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speculative and would need to be evaluated in future research.  
Public Health Implications 
 The purpose of this dissertation was to develop a better understanding of the factors that  
may impact the cognitive ageing process across the lifespan; the decline which occurs in various  
cognitive domains from early adulthood to old age. The existing literature has mainly focused on  
older adults, a population that is known to be affected by dementia; however, cognitive decline  
can develop over years or decades prior to symptom manifestation (Nelson et al., 2009).  
Therefore, it is pertinent that we develop a better understanding of the lifelong behavioral factors  
that may contribute to cognitive decline in late life and we believe that this can only be  
effectively achieved by implementing a life-span approach where various behavioral risk  
factors are evaluated prior to a diagnosis of dementia.  
 
It appears that increasing age is greatly accompanied by an accumulation of poor lifestyle  
 
practices. As people age, they tend to exercise their minds and bodies less, engage in sedentary  
 
activities such as television watching, and consume fewer daily servings of fruits and vegetables  
 
(Brownson et al., 2005; Stamatakis et al., 2007; Juneau & Potvin, 2010), all of which may  
 
contribute to weight gain and the development of chronic conditions. All of these negative  
 
behaviors, in turn, either individually or collectively, may contribute to the increasing prevalence  
 
of cognitive impairment (Abraham et al., 2007; Luchsinger et al., 2005).   
 
Over the past few decades, the way in which we live our daily lives has changed  
 
dramatically. Technological advances, societal influences and environmental attributes have  
 
significantly influenced the way we spend our leisure, work and travel time, and how we live our  
 
lives at home and in our communities, resulting in substantial proportions of the day spent in  
 
sedentary pursuits, or sitting (Church et al., 2011; Juneau & Potvin, 2010). However, the findings  
 
of this dissertation indicate that maintaining a physically active lifestyle at every stage of life,  
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might contribute to the preservation of cognitive functions in old age.  
 
Physical activity plays an important role in reducing vascular risk factors (Kumari &  
 
Heese, 2010; Joyner & Green, 2009); thus, reducing the need for medications, which negatively  
 
impact cognitive function (a relationship that is indicated by our findings). In addition, research  
 
findings indicate that individuals who exercised 3 or more times per week had a higher  
 
probability of being dementia-free than those who exercised fewer than 3 times per week. This  
 
suggests an inverse relationship between levels of activity and risk of cognitive decline (Laurin  
 
et al., 2001; Middleton et al., 2008). The cognitive benefits of physical activity have been  
 
observed in laboratory animals and older adults; however, more research needs to be done in  
 
younger adult populations in order to determine if there is a cumulative effect of physical activity  
 
on cognition over time. Perhaps, the earlier in their lifecycle an individual becomes physically  
 
active, maintains a healthy body weight (normal weight to overweight range) and leads a healthy  
 
lifestyle (low sedentary time, high daily intake of fruits and vegetables), the greater their brain  
 
reserve will be when they reach old age, and their risk of developing cognitive decline may be  
 
alleviated 
 
As well, along with leading a physically active lifestyle, individuals also need to ensure  
 
that they maintain a mentally stimulating one. Physical activity increases brain reserve by  
 
increasing blood flow, the number of existing capillaries and neurons and therefore reduces  
 
volumetric shrinkages that occur with age. Mentally stimulating activities such as reading,  
 
attending lectures/courses, playing card games and word games, on the other hand, may  
 
contribute to an increase in cognitive reserve. Cognitive reserve refers to the ability of the brain  
 
to tolerate the age-related changes and disease related pathology in the brain without developing  
 
clinical symptoms or signs of disease (Kramer et al., 2004). It is known that higher levels of  
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education and occupational complexity increase cognitive reserve but our findings indicate that  
 
regular engagement in cognitively stimulating leisure activities might offer protection against  
 
cognitive decline.  
 
Due to the ageing of the world’s population, dementia prevalence will continue to  
 
increase. Effective strategies to prevent cognitive decline are imperative to face the oncoming  
epidemic of dementia and cognitive diseases. Merely delaying the onset of dementia by as  
little as a year, could conceivably alleviate social and economic burdens associated with the  
disease. Lifestyle modifications, such as adhering to a healthy lifestyle including a diet that is  
rich in essential nutrients, regular exercise engagement, an adequate cardiovascular profile as  
well as challenging the brain with new information and new experiences seem to all be effective  
ways by which to preserve cognitive function and delay cognitive decline. As well, the findings  
 
of this dissertation also reinforce that cognitive decline is a complicated matter and needs to be  
 
studied as such. 
 
Strengths and Limitations 
 
The use of large Canadian and American datasets focused on variables that influence 
health and well-being as people age from early adulthood to old age, to explore the inter-
relationships of interest represents one of the strengths of this project. The exploration of  
cognitive performance at various age-groups ranging from early adulthood to old age is one of  
 
the key strengths of this project. Dementia is a condition that develops gradually and decline may  
 
be occurring years or even decades prior to symptom manifestation. Therefore, having a clearer  
 
picture of which behaviors across the lifespan may be associated with cognitive performance  
 
might allow for earlier intervention and thus delay of disease onset or even disease prevention.   
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As well, the evaluation of the relationships between various lifestyle behavioral clusters  
 
(physical activity, a wide array of lifestyle and health indicators, anthropometry) and cognitive  
 
performance across the adult life-span all represent the strengths of this project. 
 
This project is not without its limitations. First, the cross-sectional nature of the CCHS  
 
data prohibits the inference of causality, and only allows us to speculate on the existence of the  
 
various associations that exist between variables. Second, the reliance on self-reported measures  
 
of physical activity and anthropometry from both the CCHS and MIDUS datasets may have  
 
resulted in overestimations of physical activity and underestimations of anthropometry.  Third,  
 
because cognitive measures were only added in the second wave of MIDUS, although  
 
differences between MIDUS I sample characteristics and MIDUS II sample characteristics were  
 
studied, longitudinal analyses could not be performed. The impact of these limitations on the  
 
overall findings from this dissertation is an important area for future work.  
 
Future Directions 
 
 It is hoped that the findings contained within this dissertation will set the stage for future  
 
research, both by building on the current findings as well as exploring new questions which  
 
might now be generated.  First and foremost, the opinion that dementia is a concern of the  
 
old, is a notion that needs to change. Instead, it needs to be perceived as a condition that  
 
develops over many years or decades prior to the manifestation of symptoms. Therefore,  
 
cognitive function needs to be studied across the lifespan in individuals of all ages so that we  
 
might be able to pinpoint the critical points in the life cycle during which cognitive performance  
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is impacted. More longitudinal studies spanning early adulthood to old age are needed, including  
 
larger sample sizes and ideally followed for longer time frames. Future research should also  
 
include objective measures of overweight/obesity status and physical activity, with multiple  
 
measures of exposures in order to assess changes across time, as well as both survey and neuro- 
 
imaging measures of cognitive function. While the implementation of survey based measures  
 
allows for larger sample sizes (and thus more data) and are excellent for longitudinal studies and  
 
for tracking change; these tests only provide a snapshot of the current state of one’s functioning  
 
(Cullen et al., 2007). On the other hand, the advantages of neuro-imaging techniques are clear:  
 
they allow for early detection of cognitive decline and they are able to differentiate between the  
 
different types of dementia (Cullen et al., 2007). Therefore, a combination of both survey-based  
 
and neuroimaging measures will contribute to a more conclusive result. 
  
 Additionally, the development of interventions that decrease the risk of cognitive decline  
 
is critical. These interventions must include adults of all ages, young and old, in order to  
 
determine whether leading a physically active lifestyle along with eating a healthy diet, reducing  
 
sedentary time, keeping a sharp mind, maintaining a healthy body weight and so on contribute to  
 
the preservation of cognitive performance. These interventions must be comprehensive and  
 
consider a large number of variables at one time. Cognitive decline is a complicated  
 
phenomenon that occurs due to malfunctions that may occur via many different pathways  
 
including inactive lifestyle, consumption of medications, genetics or some combination of all of  
 
the above; therefore variables cannot be studied in isolation or individually.  
 
Finally, theory and theoretical constructs should be explored and potentially implemented  
 
in future interventions aimed at preserving cognitive function in order to influence behavior  
 
modification. Theoretical principles should inform and guide the design and development of  
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interventions for encouraging the engagement in any behavior, including mind-body exercise  
 
for several reasons (Glanz & Bishop, 2010). First, they indicate which variables are important,  
 
and which might exhibit a certain effect from an intervention. As well, from a more theoretical  
 
perspective, practically applying theories is important for testing their effectiveness in real world  
 
settings (Glanz & Bishop, 2010).  
 
Conclusion 
 
This work provides new insight into the lifestyle factors as well as the important inter- 
 
relationships that contribute to the maintenance of cognitive integrity throughout the adult  
 
lifespan. It also contributes to a better understanding of the means by which to delay  
 
cognitive decline, which might help in identifying key opportunities for early intervention efforts  
 
within asymptomatic individuals in order to preserve cognitive function and delay cognitive  
 
decline. Thus, modifying perceptions that cognitive decline is a concern of the old, as well as  
 
informing the public of the significance of adopting and leading physically and mentally healthy  
 
lifestyles at every age, is of the utmost importance in the pursuit for the preservation of cognitive  
 
function and the slowing of the progression of cognitive decline.  
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Age Question: What is your age? 
12 To 14 Years  
15 To 17 Years  
18 To 19 Years  
20 To 24 Years  
25 To 29 Years  
30 To 34 Years  
35 To 39 Years  
40 To 44 Years  
45 To 49 Years  
50 To 54 Years  
55 To 59 Years  
60 To 64 Years  
65 To 69 Years  
70 To 74 Years  
75 To 79 Years  
80 Years Or Older 
Sex - 1 Male 2 Female   
Concept: Marital Status  
Question: What is your marital status? Are you married, living common-law, widowed, 
separated, divorced, or single, never married? 
Married  
Common-Law  
Widowed / Separated / Divorced  
Single, Never Married  
Not Stated 
 
Concept BMI class 
Underweight 1 
Normal Weight 2 
Overweight 3 
Obese 4 
 
Concept Has high blood pressure 
Question Do you have high blood pressure?  (diagnosed by a health professional and are 
expected to last or have already lasted 6 months or more)  
1 Yes 2 No  
 
Concept Ever diagnosed with high blood pressure 
Question Have you ever been diagnosed with high blood pressure? 
1 Yes 2 No  
Concept Has diabetes 
Question (diagnosed by a health professional 6 months or more.) Do you have diabetes? 
1 Yes 2 No  
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Concept Has a mood disorder 
Question (conditions diagnosed by a health professional and that are expected to last or have 
already lasted 6 months or more. Do you have a mood disorder such as depression, bipolar 
disorder, mania or dysthymia? 
1 Yes 2 No  
 
1 Yes (Or Sometimes) 2 No  
 
Concept Daily Consumption - Total Fruits And Vegetables 
Less Than 5 Times / Servings Per Day 1  
5 To 10 Times / Servings Per Day 2  
More Than 10 Times / Servings Per Day 3 
 
Concept Leisure physical activity index 
Active 1  
Moderately Active 2  
Inactive 3 
 
Concept Type of smoker 
Question At the present time, do you smoke cigarettes daily, occasionally or not at all? 
Daily 1  
Occasionally 2  
Not At All 3 
 
Concept Ever Smoked Cigarettes Daily 
Question Have you Ever Smoked Cigarettes Daily? 
1 Yes 2 No  
 
Concept: Highest level of education 
Less Than Secondary School Graduation 1  
Sec. School. Gra,,, No Post-Sec. 2  
Some Post-Secondary Education  3 
Post-Sec Cert./Dip Or Univ. Deg 4 
 
Concept: Cognition problems (cognitive attribute of health utilities index) 
Cognition Attribute - Level 1  
Cognition Attribute - Level 2  
Cognition Attribute - Level 3  
Cognition Attribute - Level 4  
Cognition Attribute - Level 5  
Cognition Attribute - Level 6 
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Midlife in the US (MIDUS) Variables 
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Respondent's Year of Birth: Range Of Valid Values: 1920 – 1975 
Gender of Respondent:  
1 Male 2 Female 
 
Education Categories 
1 Some Grade School To Some High School 
2 Ged To Graduated High School  
3 Some College (No Bachelors Degree)  
4 Grad College To Doctorate Or Professional Degree 
 
High Blood Pressure 
Question: In the past twelve months, have you experienced or been treated for any of the 
following – High Blood Pressure Or Hypertension? 
1 Yes 2 No 
 
Diabetes Or High Blood Sugar 
Question: In the past twelve months, have you experienced or been treated for any of the 
following - 
Diabetes Or High Blood Sugar? 
1 Yes 2 No 
 
Rx For Hypertension 
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - Hypertension? 
1 Yes 2 No 
 
Rx For Diabetes 
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - Diabetes? 
1 Yes 2 No 
 
Rx For High Cholesterol 
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - High Cholesterol? 
1 Yes 2 No 
 
Summer Vigorous Activity 
Question: During the summer, how often do you engage in VIGOROUS physical activity (for 
example, running or lifting heavy objects) long enough to work up a sweat? 
1 Several Times A Week Or More  
2 About Once A Week  
3 Several Times A Month  
4 About Once A Month  
5 Less Than Once A Month  
6 Never 
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Summer Moderate Phy Activity 
Question: During the summer, how often do you engage in MODERATE physical activity (for 
example, bowling or using a vacuum cleaner)? 
1 Several Times A Week Or More  
2 About Once A Week  
3 Several Times A Month  
4 About Once A Month  
5 Less Than Once A Month  
6 Never 
 
Winter Moderate Phy Activity 
Question: What about during the winter -- how often do you engage in MODERATE physical 
activity? 
1 Several Times A Week Or More  
2 About Once A Week  
3 Several Times A Month  
4 About Once A Month  
5 Less Than Once A Month  
6 Never 
 
Times/Month Moderate Activity 
Range of valid values: 0 – 14 
Mean: 9.345±5.122 
 
Weight In Pounds 
Question: How much do you currently weigh? 
Range of valid values: 63 – 415 
Mean: 172.033±39.487 
 
Body Mass Index 
Range of valid values: 9 – 64 
Mean: 26.665±5.292 
 
High Blood Pressure Ever Diagnosed 
Question: Has a doctor ever told you that you have or had high blood pressure? 
1 yes  
2 no 
 
Ever Taken High Blood Pressure Medicine 
Question: Have you ever taken medicine prescribed by a doctor for your high blood pressure? 
1 yes  
2 no 
 
Now Taking High Blood Pressure Medicine 
Question: Are you CURRENTLY taking any prescription medications for your high blood 
pressure? 
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1 yes  
2 no 
 
Ever Smoked Cigarettes Regularly 
Question: Have you ever smoked cigarettes regularly -- that is, at least a few cigarettes every 
day? 
1 yes  
2 no 
 
Now Smoke Cigarettes Regularly 
Question: Do you smoke cigarettes regularly now? 
1 yes  
2 no 
 
High Blood Press/Hypertensn Ever (12 Mo) 
Question: In the past twelve months, have you experienced or been treated for any of the 
following – High Blood Pressure Or Hypertension? 
1 Yes  
2 No 
 
Diabetes/High Blood Sugar Ever (12 Mo) 
Question: In the past twelve months, have you experienced or been treated for any of the 
following - 
Diabetes Or High Blood Sugar? 
1 Yes  
2 No 
 
Rx Hypertension Ever  
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - Hypertension? 
1 Yes  
2 No 
 
Rx Diabetes Ever  
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - Diabetes? 
1 Yes  
2 No 
 
Rx Cholesterol Ever  
Question: During the past 30 days have you taken prescription medicine for any of the following 
conditions - High Cholesterol? 
1 Yes  
2 No 
 
Do Word Games Frequency 
140 
 
Question: How often do you...do word games such as crossword puzzles or scrabble? 
1 Daily  
2 Several Times A Week  
3 Once A Week  
4 Several Times A Month  
5 Once A Month  
6 Never 
 
Play Cards/Other Games Frequency 
Question: How often do you...play cards or other games such as bridge or chess? 
1 Daily  
2 Several Times A Week  
3 Once A Week  
4 Several Times A Month  
5 Once A Month  
6 Never 
 
Attend Lectures/Courses Frequency 
Question: How often do you...Attend Educational Lectures or Courses? 
1 Daily  
2 Several Times A Week  
3 Once A Week  
4 Several Times A Month  
5 Once A Month  
6 Never 
 
Waist Around Navel (Inches) 
Pre-question: The next questions are about body measurements. We have enclosed a tape 
measure to help you. It is yours to keep. The information will be more accurate if you follow 
these suggestions: Make 
measurements while standing. Avoid measuring over clothing (even thin clothing can add a 1/4 
inch). Try to record answers to the nearest quarter (1/4) inch. 
Question: What is your waist size--that is, how many inches around is your waist? Please 
measure at the level of your navel. 
Range: 18-65 
Mean: 37.282±5.897 
 
Hips At Widest Point (Inches) 
Question: What is your hip size--that is, how many inches do your hips measure at the widest 
point? Measure at the widest point between your waist and your thighs. 
Range: 15-72  
Mean: 41.087±5.392 
 
Waist-To-Hip Ratio 
Range: 0.5-1.617  
Mean: 0.903±0.104 
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Weight Current (Pounds) 
Question: How much do you currently weigh? 
Range: 85-450  
Mean: 178.428±42.155 
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In Studies 1 & 2 
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Study 1: 
The SURVEYREG Procedure 
  
Regression Analysis for Dependent Variable hui_cog 
Data Summary 
Number of Observations 2310 
Sum of Weights 631156.1 
Weighted Mean of hui_cog 1.74560 
Weighted Sum of hui_cog 1101749.2 
 
Fit Statistics 
R-square 0.2059 
Root MSE 1.0362 
Denominator DF 2309 
 
Class Level Information 
CLASS Variable Levels Values 
age_cat 2 1 2 
bmi 3 2 3 4 
pai 3 1 2 3 
ST 3 1 2 3  
 
Tests of Model Effects 
Effect Num DF F Value Pr > F 
Model 181 11414.4 <.0001 
Intercept 1 23.38 <.0001 
age_cat 1 0.96 0.3275 
bmi 2 1.83 0.1607 
pai 2 3.35 0.0023 
ST 2 2.43 0.0097 
age_cat*bmi 2 2.01 0.1342 
age_cat*pai 2 0.37 0.6909 
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Tests of Model Effects 
Effect Num DF F Value Pr > F 
age_cat*ST 2 1.77 0.0685 
bmi*pai 4 0.06 0.9927 
bmi*ST 4 1.55 0.0651 
pai*ST 4 3.04 <.0001 
age*bmi*pai 4 1.38 0.1932 
age_cat*bmi*ST 4 2.56 0.0003 
age_cat*pai*ST 4 4.18 <.0001 
age_cat*bmi*pai*ST 16 2.71 <.0001 
  
After finding a significant relationship between age*bmi*pai*ST; analyses were further stratified 
by age. 
Younger Adults 
Data Summary 
Number of Observations 1215 
Sum of Weights 425539.1 
Weighted Mean of hui_cog 1.68413 
Weighted Sum of hui_cog 716663.1 
 
Fit Statistics 
R-square 0.2100 
Root MSE 1.0015 
Denominator DF 1214 
 
Class Level Information 
CLASS Variable Levels Values 
bmi 3 2 3 4 
pai 3 1 2 3 
ST 3 1 2 3  
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Tests of Model Effects 
Effect Num DF F Value Pr > F 
Model 81 9.55 <.0001 
Intercept 1 2014.60 <.0001 
bmi 2 0.58 0.5593 
pai 2 5.79 0.0031 
ST 2 1.96 0.0403 
bmi*pai 4 3.52 0.0072 
bmi*ST 4 2.70 0.0002 
pai*ST 4 4.62 <.0001 
bmi*pai*ST 8 3.68 <.0001 
 
Older Adults 
Data Summary 
Number of Observations 1095 
Sum of Weights 205617.0 
Weighted Mean of hui_cog 1.87283 
Weighted Sum of hui_cog 385086.0 
 
Fit Statistics 
R-square 0.1645 
Root MSE 1.1105 
Denominator DF 1094 
 
Class Level Information 
CLASS Variable Levels Values 
bmi 3 2 3 4 
pai 3 1 2 3 
ST 3 1 2 3  
 
Tests of Model Effects 
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Effect Num DF F Value Pr > F 
Model 81 10.20 <.0001 
Intercept 1 2024.22 <.0001 
bmi 2 2.04 0.1303 
pai 2 3.44 0.0097 
ST 2 1.71 0.0815 
bmi*pai 4 3.20 0.0127 
bmi*ST 4 1.90 0.0128 
pai*ST 4 3.10 <.0001 
bmi*pai*ST 8 2.09 0.0003 
 
The means for the figures 1 and 2 were obtained via Proc survey reg procedure in SAS, using the  LSMEANS 
options. 
Study 2: 
The SURVEYREG Procedure 
  
Regression Analysis for Dependent Variable hui_cog 
Data Summary 
Number of Observations 2130 
Sum of Weights 598552.2 
Weighted Mean of hui_cog 1.71955 
Weighted Sum of hui_cog 1029240.5 
 
Fit Statistics 
R-square 0.1859 
Root MSE 1.0362 
Denominator DF 2129 
 
Class Level Information 
CLASS Variable Levels Values 
age_cat 2 1 2 
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Class Level Information 
CLASS Variable Levels Values 
bmi 3 2 3 4 
pai 3 1 2 3 
education 4 1 2 3 4 
fvtot 3 1 2 3 
 
Tests of Model Effects 
Effect Num DF F Value Pr > F 
Model 129 2368529 <.0001 
Intercept 1 2175.39 <.0001 
age_cat 1 10.10 0.0015 
bmi 2 17.61 <.0001 
pai 2 18.42 <.0001 
education 3 8.34 <.0001 
fvtot 2 12.21 <.0001 
age_cat*bmi 2 0.18 0.8351 
age_cat*pai 2 3.05 0.0474 
age_cat*education 3 2.30 0.0753 
age_cat*fvtot 2 3.74 0.0239 
bmi*pai 4 3.38 0.0091 
bmi*education 6 7.67 <.0001 
bmi*fvtot 4 4.68 0.0009 
pai*education 6 2.44 0.0236 
pai*fvtot 4 2.16 0.0711 
age_cat*bmi*education 6 1.35 0.2305 
age_cat*pai*education 6 3.14 0.0046 
age_cat*education*fvtot 11 8.66 <.0001 
bmi*pai*education 12 6.82 <.0001 
age_cat*bmi*pai 4 15.88 <.0001 
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Tests of Model Effects 
Effect Num DF F Value Pr > F 
age_cat*bmi*fvtot 4 1.61 0.1692 
age_cat*pai*fvtot 4 6.08 <.0001 
age_cat*bmi*pai*fvtot 15 6.28 <.0001 
age_cat*bmi*pai*education*fvtot 62 5.45 <.0001 
 
After finding a significant relationship between age*bmi*pai*fvtot and 
age*bmi*pai*fvtot*ecucation; analyses were further stratified by age. 
Younger Adults 
Data Summary 
Number of Observations 1150 
Sum of Weights 411837.4 
Weighted Mean of hui_cog 1.66103 
Weighted Sum of hui_cog 684074.1 
 
Fit Statistics 
R-square 0.1870 
Root MSE 1.0041 
Denominator DF 1149 
 
Class Level Information 
CLASS Variable Levels Values 
bmi 3 2 3 4 
pai 3 1 2 3 
education 4 1 2 3 4 
fvtot 3 1 2 3 
 
Tests of Model Effects 
Effect Num DF F Value Pr > F 
Model 63 17.54 <.0001 
149 
 
Tests of Model Effects 
Effect Num DF F Value Pr > F 
Intercept 1 1616.55 <.0001 
bmi 2 11.71 <.0001 
pai 2 12.85 <.0001 
education 3 8.24 <.0001 
fvtot 2 16.38 <.0001 
bmi*pai 4 7.71 <.0001 
bmi*education 6 3.20 0.0040 
bmi*fvtot 4 3.77 0.0047 
pai*education 6 1.65 0.1295 
pai*fvtot 4 8.47 <.0001 
bmi*pai*education 12 3.01 0.0004 
bmi*pai*fvtot 7 2.59 0.0118 
bmi*pai*education*fvtot 29 5.63 <.0001 
 
Older Adults 
Data Summary 
Number of Observations 980 
Sum of Weights 186714.7 
Weighted Mean of hui_cog 1.84863 
Weighted Sum of hui_cog 345166.3 
 
Fit Statistics 
R-square 0.1689 
Root MSE 1.1008 
Denominator DF 979 
 
Class Level Information 
CLASS Variable Levels Values 
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Class Level Information 
CLASS Variable Levels Values 
bmi 3 2 3 4 
pai 3 1 2 3 
education 4 1 2 3 4 
fvtot 3 1 2 3 
 
Tests of Model Effects 
Effect Num DF F Value Pr > F 
Model 64 16.07 <.0001 
Intercept 1 931.85 <.0001 
bmi 2 6.45 0.0017 
pai 2 0.87 0.4196 
education 3 5.26 0.0013 
fvtot 2 4.28 0.0141 
bmi*pai 4 6.54 <.0001 
bmi*education 6 4.74 <.0001 
bmi*fvtot 4 3.44 0.0083 
pai*education 6 4.23 0.0003 
pai*fvtot 4 5.46 0.0002 
bmi*pai*education 12 9.80 <.0001 
bmi*pai*fvtot 8 3.17 0.0015 
bmi*pai*education*fvtot 32 7.59 <.0001 
The means for the figures 1, 2 and 3 were obtained via Proc survey reg procedure in SAS, using the  LSMEANS 
options. 
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In Studies 3 & 4 
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Study 3: Episodic Memory 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 139 714.047663 5.137034 6.16 <.0001 
Error 3346 2788.994504 0.833531     
Corrected Total 3485 3503.042167       
 
R-Square Coeff Var Root MSE episodic_memory Mean 
0.203836 3937.261 0.912979 0.023188 
 
Source DF Type III SS Mean Square F Value Pr > F 
Whr 3 72.4646375 24.1548792 28.98 <.0001 
Age 3 83.7849990 27.9283330 33.51 <.0001 
Meds 2 4.2654145 2.1327073 2.56 0.0776 
Mvpa 2 6.6656476 3.3328238 4.00 0.0184 
age*mvpa 6 9.5323602 1.5887267 1.91 0.0761 
meds*mvpa 4 0.5068300 0.1267075 0.15 0.9622 
whr*mvpa 6 8.2960041 1.3826673 1.66 0.1270 
whr*meds 6 1.4153120 0.2358853 0.28 0.9452 
age*meds*mvpa 18 33.3633520 1.8535196 10.22 0.0022 
whr*age*meds*mvpa 89 105.2283136 1.1823406 13.42 0.0006 
 
After a significant interaction was found between whr*age*meds*mvpa; analyses were further stratified by age. 
Study 3: Executive Function 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 139 839.650026 6.040648 7.99 <.0001 
Error 3353 2534.556631 0.755907     
Corrected Total 3492 3374.206656       
 
R-Square Coeff Var Root MSE executive_function Mean 
0.248844 6108.037 0.869429 0.014234 
Source DF Type III SS Mean Square F Value Pr > F 
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R-Square Coeff Var Root MSE executive_function Mean 
whr 3 9.6267983 3.2089328 4.25 0.0053 
age 3 101.9026966 33.9675655 44.94 <.0001 
meds 2 9.5658695 4.7829348 6.33 0.0018 
mvpa 2 16.6967596 8.3483798 11.04 <.0001 
age*mvpa 6 7.4422289 1.2403715 1.64 0.1317 
meds*mvpa 4 5.2101401 1.3025350 1.72 0.1420 
whr*mvpa 6 3.4660835 0.5776806 0.76 0.5980 
whr*meds 6 1.8365400 0.3060900 0.40 0.8762 
age*meds*mvpa 18 19.2062064 1.0670115 5.41 0.0024 
whr*age*meds*mvpa 89 68.6964664 0.7718704 14.33 <.0001 
 
After a significant interaction was found between whr*age*meds*mvpa; analyses were further stratified by age. 
The means for the figures 2-3 were obtained via Proc Proc GLM in SAS, using the  LSMEANS options. 
Study 4: Episodic Memory 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 23 432.349666 18.797812 21.13 <.0001 
Error 3592 3195.540316 0.889627     
Corrected Total 3615 3627.889982       
 
R-Square Coeff Var Root MSE episodic_memory Mean 
0.119174 4363.574 0.943200 0.021615 
 
Source DF Type III SS Mean Square F Value Pr > F 
mvpa 2 19.8354892 19.9177446 19.15 <.0001 
cog_stim 1 17.4448382 12.4448382 11.61 <.0001 
age 3 156.5165268 52.1721756 58.64 <.0001 
mvpa*age 6 0.9924522 0.1654087 8.19 0.0098 
cog_stim*age 3 1.0566820 0.3522273 6.40 0.0176 
mvpa*cog_stim 2 0.8206186 0.4103093 7.46 0.0063 
mvpa*cog_sti*age 6 4.1958438 0.6993073 13.67 0.0011 
 
After a significant interaction was found between age*cog_stim*mvpa; analyses were further stratified by age. 
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Study 4: Executive Function 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 23 780.340039 33.927828 45.05 <.0001 
Error 3600 2711.245431 0.753124     
Corrected Total 3623 3491.585469       
 
R-Square Coeff Var Root MSE executive_function Mean 
0.223492 4409.834 0.867827 0.019679 
Source DF Type III SS Mean Square F Value Pr > F 
mvpa 2 68.5843358 38.2921679 51.17 <.0001 
cog_stim 1 38.5354243 34.5354243 45.43 <.0001 
age 3 248.6557100 82.8852367 110.06 <.0001 
mvpa*age 6 4.4023150 0.7337192 9.97 0.0044 
cog_stim*age 3 2.6611737 0.8870579 7.35 0.0166 
mvpa*cog_stim 2 0.8684397 0.4342199 7.50 0.0156 
mvpa*cog_stim*age 6 3.1749155 0.5291526 15.70 0.0003 
 
After a significant interaction was found between age*cog_stim*mvpa; analyses were further stratified by age. 
The means for the figures 2-5 were obtained via Proc Proc GLM in SAS, using the  LSMEANS options. 
 
 
 
 
 
 
 
 
 
 
